<SEC-DOCUMENT>0001193125-24-236461.txt : 20241011
<SEC-HEADER>0001193125-24-236461.hdr.sgml : 20241011
<ACCEPTANCE-DATETIME>20241011081052
ACCESSION NUMBER:		0001193125-24-236461
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20241010
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241011
DATE AS OF CHANGE:		20241011

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COHERENT CORP.
		CENTRAL INDEX KEY:			0000820318
		STANDARD INDUSTRIAL CLASSIFICATION:	OPTICAL INSTRUMENTS & LENSES [3827]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				251214948
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39375
		FILM NUMBER:		241366445

	BUSINESS ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
		BUSINESS PHONE:		724-352-4455

	MAIL ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	II-VI INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d888602d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cohr="http://www.coherent.com/20241010" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-402">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-10-10_to_2024-10-10">0000820318</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cohr-20241010.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-10-10_to_2024-10-10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000820318</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-10-10</xbrli:startDate> <xbrli:endDate>2024-10-10</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-413">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-10-10_to_2024-10-10" format="ixt:datemonthdayyearen" id="ixv-414">October&#160;10, 2024</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-415">Coherent Corp.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-10-10_to_2024-10-10" format="ixt-sec:stateprovnameen" id="ixv-416">Pennsylvania</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-417">001-39375</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-418">25-1214948</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-419">375 Saxonburg Boulevard</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-420">Saxonburg</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-10-10_to_2024-10-10" format="ixt-sec:stateprovnameen" id="ixv-421">Pennsylvania</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-422">16056</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) (Zip Code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-423">(724)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-424">352-4455</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-10-10_to_2024-10-10" format="ixt-sec:boolballotbox" id="ixv-425">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-10-10_to_2024-10-10" format="ixt-sec:boolballotbox" id="ixv-426">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-10-10_to_2024-10-10" format="ixt-sec:boolballotbox" id="ixv-427">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-10-10_to_2024-10-10" format="ixt-sec:boolballotbox" id="ixv-428">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-429">Common Stock, no par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-430">COHR</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-10-10_to_2024-10-10" format="ixt-sec:exchnameen" id="ixv-431">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-10-10_to_2024-10-10" format="ixt-sec:boolballotbox" id="ixv-432">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;10, 2024, Coherent Corp. (the &#8220;Company&#8221;) appointed Sherri R. Luther as the Company&#8217;s Chief Financial Officer (&#8220;CFO&#8221;) and Treasurer, effective October&#160;11, 2024 (the &#8220;Start Date&#8221;), replacing Richard J. Martucci, who has served as the Company&#8217;s Interim CFO since September&#160;30, 2023. Mr.&#160;Martucci will remain with the Company in a <span style="white-space:nowrap">non-executive</span> officer role. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&#160;Luther, age 59, has served as the chief financial officer of Lattice Semiconductor Corporation (&#8220;Lattice&#8221;) since January 2019. Prior to joining Lattice, Ms.&#160;Luther was a senior financial executive at Coherent, Inc. for over sixteen years, and most recently served as its Corporate Vice President of Finance. Prior to joining Coherent, Inc., Ms.&#160;Luther held a number of senior finance and accounting positions at companies including Quantum, Ultra Network Technologies and Arthur Andersen. Ms.&#160;Luther is a Certified Public Accountant in the State of California and graduated from the Executive MBA Program at Stanford University Graduate School of Business. She holds a Bachelor of Business Administration, with a dual major in Accounting and Finance, from Wright State University. She serves on the Board of Directors of Silicon Labs and is also NACD (National Association of Corporate Directors) Directorship Certified. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no arrangements or understandings between Ms.&#160;Luther and any other persons pursuant to which Ms.&#160;Luther was appointed CFO and Treasurer. Ms.&#160;Luther does not have any family relationship with any of the Company&#8217;s directors or executive officers or any persons nominated or chosen by the Company to be a director or executive officer. Ms.&#160;Luther has no direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a) of <span style="white-space:nowrap">Regulation&#160;S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with her appointment as CFO and Treasurer, Ms.&#160;Luther entered into an offer letter agreement with the Company (the &#8220;Offer Letter&#8221;) on October&#160;10, 2024, effective on the Start Date. Pursuant to the Offer Letter, Ms.&#160;Luther will serve as CFO and Treasurer reporting to James R. Anderson, the Company&#8217;s Chief Executive Officer. The Offer Letter does not have a specific term and provides that Ms.&#160;Luther will be an <span style="white-space:nowrap">at-will</span> employee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offer Letter provides as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Ms.&#160;Luther&#8217;s annual base salary will be $625,000, subject adjustment based on an annual review by the Compensation and Human Capital Committee of the Company&#8217;s Board of Directors. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Ms.&#160;Luther will be eligible to earn annual incentive compensation awards beginning for fiscal year 2025, subject to the terms and conditions of the Company&#8217;s annual incentive plans, with a target annual bonus of 85% of her base salary. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Ms.&#160;Luther will be eligible to receive long-term incentive awards under the Company&#8217;s Omnibus Incentive Plan consistent with the design for the Company&#8217;s other executive officers. For fiscal year 2025, the aggregate target grant date value of the long-term incentive awards for Ms.&#160;Luther equals $3,500,000, provided 40% as time-vesting restricted stock units (&#8220;RSU&#8221;) and 60% as performance stock units (&#8220;PSUs,&#8221; together with the &#8220;RSUs,&#8221; the &#8220;Fiscal Year 2025 Awards&#8221;). As an inducement to her acceptance of the Company&#8217;s offer of employment, the Fiscal Year 2025 Awards will be granted on the Start Date as part of her <span style="white-space:nowrap">sign-on</span> inducement equity awards as described below. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Ms.&#160;Luther will receive a cash <span style="white-space:nowrap">sign-on</span> bonus in the amount of $500,000 to be paid in a lump sum on the first regular payroll date following the Start Date. If Ms.&#160;Luther&#8217;s employment with the Company terminates before the second anniversary of the Start Date either by her voluntary resignation other than for &#8220;good reason&#8221; or by the Company for &#8220;cause,&#8221; then Ms.&#160;Luther will be required promptly repay to the Company the full gross amount of the <span style="white-space:nowrap">sign-on</span> bonus. For all purposes of the Offer Letter and the awards provided under it, &#8220;cause&#8221; and &#8220;good reason&#8221; are as defined in the Company&#8217;s Revised Executive Severance Plan (&#8220;RESP&#8221;) and the standard form of Participation Agreement executed by Ms.&#160;Luther under the RESP (the &#8220;Participation Agreement&#8221;). </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Ms.&#160;Luther will receive new hire equity awards effective on the Start Date as an inducement to Ms.&#160;Luther accepting the Company&#8217;s offer of employment. The inducement equity awards will be in the total amount of $17,400,000, of which $3,500,000 represents the value of the Fiscal Year 2025 Awards and $13,900,000 represents <span style="white-space:nowrap">sign-on</span> awards in part to recognize equity awards that will forfeit from her current employer (the <span style="white-space:nowrap">&#8220;Sign-On</span> Awards,&#8221; together with the Fiscal Year 2025 Awards, the &#8220;Inducement Awards&#8221;). The material features of the Inducement Awards are as follows: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:14%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$1,400,000 of the total award value (representing 40% of the Fiscal Year 2025 Awards value) will be delivered as an award of time-vesting RSUs that vest annually over three years starting on the first anniversary of the Start Date. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:14%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$5,560,000 of the total award value (representing 40% of <span style="white-space:nowrap">Sign-On</span> Awards value) will be delivered as an award of time-vesting RSUs that vest annually over two years starting on the first anniversary of the Start Date. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:14%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The remaining $10,440,000 of the total Inducement Awards value (representing 60% of both the Fiscal Year 2025 Awards value and <span style="white-space:nowrap">Sign-On</span> Awards value) will be delivered as an award of PSUs. The PSUs will be earned over an approximate <span style="white-space:nowrap">3-year</span> performance period (beginning on the Start Date and ending on the last day of fiscal year 2027) based on relative total shareholder return (&#8220;rTSR&#8221;) performance similar to the Company&#8217;s fiscal year 2025 rTSR PSUs awarded to other executive officers in August 2024. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:14%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The number of such RSUs and target number of PSUs will be determined based on the <span style="white-space:nowrap">30-day</span> trailing average of the market price of the Company&#8217;s common stock immediately prior to the Start Date (rounded up to the next whole share). </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:14%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Inducement Awards will have vesting treatment on termination of employment or &#8220;change in control&#8221; (as defined in the Company&#8217;s Omnibus Incentive Plan) consistent with the Company&#8217;s standard terms for executive officers, including in accordance with the terms of the RESP and her Participation Agreement. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:14%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Inducement Awards will be granted outside of the Company&#8217;s Omnibus Incentive Plan as stand-alone inducement awards as permitted by Section&#160;303A.08 of the New York Stock Exchange&#8217;s listing rules (and subject to compliance with those listing rules). </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Ms.&#160;Luther will be eligible to participate in the Company&#8217;s employee benefit plans generally available to senior executives of the Company. She will receive severance protection under the RESP and her Participation Agreement. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per the Offer Letter, Ms.&#160;Luther will be subject to the post-employment covenants specified in the RESP and her Participation Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The description of the Offer Letter as summarized above is qualified in its entirety by reference to the copy of the full text of the Offer Letter, which is filed as Exhibit 10.1 to this Current Report <span style="white-space:nowrap">on&#160;Form&#160;8-K&#160;and&#160;which</span> is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;7.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the press release regarding this announcement of Ms.&#160;Luther&#8217;s appointment is furnished as Exhibit&#160;99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated into this Item 7.01 by reference thereto. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in Item 7.01 to this Current Report <span style="white-space:nowrap">on&#160;Form&#160;8-K,&#160;including&#160;the</span> exhibit furnished pursuant to Item 99.1, shall not be deemed &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities under that Section. Furthermore, the information in this Item 7.01 of this Current Report <span style="white-space:nowrap">on&#160;Form&#160;8-K,&#160;including&#160;the</span> exhibit furnished pursuant to Item 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, the Exchange Act, regardless of any general incorporation language contained in such filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d888602dex101.htm">Offer Letter between Sherri Luther and Coherent Corp.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d888602dex991.htm">Press Release dated October&#160;11, 2024 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104.0</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">Coherent Corp.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: October&#160;11, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ronald Basso</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Ronald Basso</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Legal and Compliance Officer&#160;&amp; Corporate Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d888602dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g888602g1010080119139.jpg" ALT="LOGO" STYLE="width:2.30417in;height:0.466667in;">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:16.00em; font-size:10pt; font-family:Times New Roman">Coherent Corp.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:16.00em; font-size:10pt; font-family:Times New Roman">375 Saxonburg Blvd.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:16.00em; font-size:10pt; font-family:Times New Roman">Saxonburg, PA</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; text-indent:16.00em; font-size:10pt; font-family:Times New Roman">16056-9499 USA</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;8, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sherri
Luther </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sherri: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Coherent Corp. (the
&#147;Company,&#148; &#147;we&#148; or &#147;us&#148;), and subject to the approval of the Compensation and Human Capital Committee of the Company, I am pleased to confirm with you the terms of our offer of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.&#8195;<U>Start Date, Position and Duties</U>. Your start date will be October&nbsp;11, 2024, or such other date as we may mutually agree (the &#147;Start
Date&#148;). You will serve as the Company&#146;s Chief Financial Officer&nbsp;&amp; Treasurer, reporting to me, with duties and authority consistent with such position. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be expected to perform your duties primarily from our Santa Clara, California office, subject to reasonable business travel consistent with your
duties as the Chief Financial Officer&nbsp;&amp; Treasurer of a globally operating public company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During your employment, you will: (i)&nbsp;devote
substantially all your working time and attention to the business and affairs of the Company (excluding any vacation, sick leave or other approved leave to which you are entitled), render such services to the best of your ability, and use your
reasonable best efforts to promote the interests of the Company, (ii)&nbsp;not engage in any other employment, consulting or other business activity that would create a conflict of interest with your services to the Company, (iii)&nbsp;not assist
any person or entity in competing with the Company or in preparing to compete with the Company and (iv)&nbsp;comply with the Company&#146;s policies and rules, as they may be in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.&#8195;<U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Employment-at-Will</FONT></FONT></U>. Your employment with the Company will be <FONT
STYLE="white-space:nowrap">at-will.</FONT> This means either you and/or the Company will be free to terminate this employment relationship at any time, with or without cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.&#8195;<U>FY25 and Inducement Equity Awards</U>. You will receive the following awards on the Start Date. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Effective on the Start Date and as an inducement to your acceptance of this offer, you will receive equity
awards in the total amount of $17,400,000, of which $3,500,000 represents the value of the Company&#146;s FY25 awards and $13,900,000 represents <FONT STYLE="white-space:nowrap">sign-on</FONT> inducement awards (to recognize equity awards you will
forfeit from your current employer). These equity awards will be delivered as follows: </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">RSUs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">$1,400,000 of the total FY25 awards value (representing 40% of the FY25 awards value) will be delivered as
time-vesting restricted stock units (the &#147;RSUs&#148;) with <FONT STYLE="white-space:nowrap">one-third</FONT> vesting on the first anniversary of the Start Date, <FONT STYLE="white-space:nowrap">one-third</FONT> vesting on the second anniversary
of the Start Date, and the final <FONT STYLE="white-space:nowrap">one-third</FONT> vesting on the third anniversary of the Start Date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The $5,560,000 of the total inducement awards value (representing 40% of the inducement awards value) will be
delivered as time-vesting restricted stock units (the &#147;RSUs&#148;) with 50% vesting on the first anniversary of the Start Date and 50% vesting on the second anniversary of the Start Date. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The number of RSUs will be determined based on the <FONT STYLE="white-space:nowrap">30-day</FONT> trailing
average of the market price of the Company&#146;s common stock immediately prior to the Start Date (rounded up to the next whole share), with such other terms and conditions of the FY25 RSU awards granted to the Company&#146;s executive officers in
August 2024. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">PSUs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">$2,100,000 of the total FY25 awards value (representing 60% of the FY25 awards value) will be delivered as
performance stock units (the &#147;PSUs&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">$8,340,000 of the total inducement awards value (representing 60% of the FY25 awards value) will be delivered
as PSUs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The target number of Inducement PSUs will be determined based on the
<FONT STYLE="white-space:nowrap">30-day</FONT> trailing average of the market price of the Company&#146;s common stock immediately prior to the Start Date (rounded up to the next whole share). The Inducement PSUs will be earned over an approximate <FONT
STYLE="white-space:nowrap">3-year</FONT> performance period (beginning on the Start Date and ending on the last day of FY27) based on relative total shareholder return (&#147;rTSR&#148;) performance similar to the Company&#146;s FY25 rTSR PSU awards
and with such other terms and conditions of such FY25 awards granted to the Company&#146;s executive officers in August 2024. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each of the FY25 and inducement equity awards will have vesting treatment on termination of employment or
change in control consistent with the Company&#146;s standard terms for executive officers, subject to the terms and conditions of (i)&nbsp;the Company&#146;s Revised Executive Severance Plan attached as Annex A (the &#147;RESP&#148;) to the
Participation Agreement attached hereto as Exhibit I (the &#147;Participation Agreement&#148;)) and (ii)&nbsp;the Participation Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.&#8195;<U><FONT STYLE="white-space:nowrap">Sign-On</FONT> Bonus</U>. You will receive a <FONT STYLE="white-space:nowrap">sign-on</FONT> bonus in the gross
amount of $500,000, payable in a single cash payment (after required tax withholdings) on the first regular payroll date following the Start Date. Should you voluntarily resign your position other than for &#147;Good Reason&#148; (as defined in the
Participation Agreement) or should the Company </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
terminate your employment for Cause (as defined in the RESP as defined below), in either case prior to the second anniversary of the Start Date, you will be required to promptly repay the full
gross amount of the <FONT STYLE="white-space:nowrap">sign-on</FONT> bonus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.&#8195;<U>Compensation and Benefits</U>. We will provide you with the
following compensation and benefits during your employment: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Base Salary</I>. You will receive base salary at the annual rate of $625,000, payable in accordance with the
Company&#146;s regular payroll practices, through September&nbsp;1, 2025. At least annually beginning in August 2025, the Compensation and Human Capital Committee of the Board (the &#147;Committee&#148;) will consider whether, in its discretion, to
increase or decrease your rate of base salary, based on market trends, internal considerations, performance or such other factors as the Committee may determine. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Annual Incentive Compensation</I>. You will have a target annual cash incentive award for FY25 equal to 85%
of your base salary (<I>i.e.</I>, target award of $531,250), delivered in the same form and on the same terms as determined for the Company&#146;s other executive officers for FY25, including in a combination of awards under the Bonus Incentive Plan
(with a target equal to 8% of your salary) and Goals Results Incentive Program (for the balance of the target). Your target annual incentive award for years after FY25 will be as determined by the Compensation Committee. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Long-Term Incentive Awards</I>. You will receive annual long-term incentive awards in such value as
determined by the Committee and in such mix and on such terms as the Committee may determine, consistent with the design for the Company&#146;s other executive officers. Your awards for FY25 are reflected in the awards described above in
Section&nbsp;3. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Benefits</I>. You will be entitled to participate in all retirement, health and welfare, vacation and other
benefit plans and arrangements generally available to other senior executives of the Company in accordance with the terms and provisions of such plans. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Severance Protection</I>. You will be offered participation in the RESP. You and the Company agree to
execute the Participation Agreement on the Start Date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Indemnification Agreement</I>. You will be offered our standard Indemnification Agreement in the form
attached hereto as Exhibit II, to be executed by you and the Company on your Start Date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">g.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Business Expenses</I>. We will reimburse you for reasonable and necessary travel and accommodation costs,
entertainment and other business expenses incurred as a necessary part of discharging your duties hereunder, subject to our standard expense reimbursement policies. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.&#8195;<U>Covenants</U>. You will be subject to the restrictive covenants set forth in Article VI of the RESP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.&#8195;<U>Miscellaneous</U>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>No Conflicts</I>. By signing this letter, you represent to the Company that your
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
acceptance of this offer and agreement to accept employment with the Company under these terms will not conflict with, violate or constitute a breach of any employment or other agreement to which
you are a party and that you are not required to obtain the consent of any person, firm, corporation or other entity in order to accept this offer of employment. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Successors and Assigns</I>. This letter shall inure to the benefit of and be binding upon (i)&nbsp;the
Company and its successors and assigns and (ii)&nbsp;you and your heirs and legal representatives, except that your duties and responsibilities under this letter that are of a personal nature and will not be assignable or delegable in whole or in
part without our prior written consent. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Entire Agreement</I>. This letter, including each exhibit, sets forth the entire present agreement of the
parties concerning the subjects covered herein. There are no promises, understandings, representations, or warranties of any kind concerning those subjects except as expressly set forth herein or therein. Any modification of this letter must be in
writing and signed upon the express consent of all parties. Any attempt to modify this letter, orally, or in writing not executed by all parties, will be void. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Enforceability</I>. If any provision of this letter, or its application to anyone or under any
circumstances, is adjudicated to be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability will not affect any other provision or application of this letter which can be given effect without the invalid or unenforceable
provision or application and will not invalidate or render unenforceable such provision or application in any other jurisdiction. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Governing Law</I>. This letter shall be governed and interpreted in accordance with the laws of the
Commonwealth of Pennsylvania without regard to its conflict of laws provision. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Waivers</I>. No failure on the part of any party to enforce any provisions of this letter will act as a
waiver of the right to enforce that provision. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">g.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Withholding</I>. All payments of compensation due to you by the Company shall be net of any tax or other
amounts required to be withheld by the Company under applicable law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">h.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Section</I><I></I><I>&nbsp;409A</I>. This letter is intended to comply with Section&nbsp;409A of the
Internal Revenue Code of 1986, as amended (the &#147;Code&#148;) or an exemption thereto, and, to the extent necessary in order to avoid the imposition of an additional tax on you under Section&nbsp;409A of the Code, payments may only be made under
this letter upon an event and in a manner permitted by Section&nbsp;409A of the Code. Any payments or benefits that are provided upon a termination of employment shall, to the extent necessary in order to avoid the imposition of any additional tax
on you under Section&nbsp;409A of the Code, not be provided unless such termination constitutes a &#147;separation from service&#148; within the meaning of Section&nbsp;409A of the Code. Any payments that qualify for the &#147;short term
deferral&#148; exception or another exception under Section&nbsp;409A of the Code shall be paid under the applicable exception. Notwithstanding anything in this letter to the contrary, if you are considered a &#147;specified employee&#148; (as
defined in Section&nbsp;409A of the Code), any amounts paid or provided under this letter due to your separation from service shall, to the extent necessary in order to avoid </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
the imposition of an additional tax on you under Section&nbsp;409A of the Code, be delayed for six months after your &#147;separation from service&#148; within the meaning of Section&nbsp;409A of
the Code, and the accumulated amounts shall be paid in a lump sum within 10 calendar days after the end of the <FONT STYLE="white-space:nowrap">6-month</FONT> period. If you die during the <FONT STYLE="white-space:nowrap">6-month</FONT> postponement
period prior to the payment of benefits, any payment amount that was deferred on account of Section&nbsp;409A of the Code shall be paid to the personal representative of your estate within 60 calendar days after the date of your death. For purposes
of Section&nbsp;409A of the Code, the right to a series of installment payments under this letter shall be treated as a right to a series of separate payments. In no event may you, directly or indirectly, designate the calendar year of a payment.
All reimbursements and in kind benefits provided under this letter shall be made or provided in accordance with the requirements of Section&nbsp;409A of the Code, including, where applicable, the requirement that (i)&nbsp;any reimbursement is for
expenses incurred during the period of time specified in this letter, (ii)&nbsp;the amount of expenses eligible for reimbursement, or in kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in
kind benefits to be provided, in any other calendar year, (iii)&nbsp;the reimbursement of an eligible expense will be made no later than the last calendar day of the calendar year following the year in which the expense is incurred, and
(iv)&nbsp;the right to reimbursement or in kind benefits is not subject to liquidation or exchange for another benefit. The Company makes no representations that the payments and benefits provided under this letter comply with Section&nbsp;409A of
the Code and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by you on account of noncompliance with Section&nbsp;409A of the Code. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Amendment</I>. This letter, including each exhibit, may be amended or modified only by a written instrument
signed by you and by a duly authorized representative of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">j.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Other Provisions</I>. You acknowledge that you have received and read copies of the Company&#146;s Stock
Ownership Guidelines for Executive Officers and Other Key Executives and the Company&#146;s Clawback Policy, and you will sign the required acknowledgement form for the Clawback Policy. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If these provisions are agreeable to you, please sign one copy of this letter and return it to me. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ James R. Anderson </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James R. Anderson </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agreed to and Accepted </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#8195;/s/ Sherri Luther</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sherri Luther</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g888602g1010080119139.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Exhibit I to Sherri Luther Offer Letter </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COHERENT CORP., 375 Saxonburg Boulevard, Saxonburg, PA 16056 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">General Offices: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">724-352-4455</FONT></FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>COHERENT CORP. REVISED EXECUTIVE SEVERANCE PLAN </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Participation Agreement </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Class 1) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participant Name</B>:
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;&#8195;&#8195;&#8195;&#8195;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Primary Work
Location</B>: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;&#8195;&#8195;&#8195;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Participation Agreement
(this &#147;<B>Agreement</B>&#148;) is made and entered into by and between Coherent Corp., a Pennsylvania corporation, and/or your employer (the &#147;<B>Company</B>&#148;), and the undersigned individual (&#147;<B>you</B>&#148;), who is an
employee of the Company and/or an Affiliate of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted the Coherent Corp. Revised Executive Severance Plan (the
&#147;<B>Plan</B>&#148;). Unless otherwise defined in this Agreement, any capitalized terms used in this Agreement will have the meanings set forth in the Plan. A copy of the Plan is attached as <U>Annex A</U> and is deemed to be part of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has selected you to become a Participant in the Plan. Under the Plan, you may become entitled to certain termination benefits if
you incur a Qualifying Termination and you otherwise satisfy all of the terms and conditions of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By executing this Agreement, you acknowledge
and agree that you are a Participant in the Plan, and that any termination benefits that you may become entitled to receive under the Plan will be based on the following periods and multipliers that have been established by the Company: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Timing of Date of Termination</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Applicable<BR>Severance<BR>Multiplier</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Applicable<BR>Bonus<BR>Multiplier</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Applicable<BR>Benefits<BR>Multiplier</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Applicable<BR>Protection<BR>Period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date of Termination during a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12&nbsp;months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12&nbsp;months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD ROWSPAN="2" NOWRAP VALIGN="middle">&nbsp;</TD>
<TD ROWSPAN="2" NOWRAP VALIGN="middle" ALIGN="right">18&nbsp;months</TD>
<TD ROWSPAN="2" NOWRAP VALIGN="middle">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date of Termination during a CIC Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24 months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18 months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, for a Qualifying Termination during a CIC Period, all Equity Awards shall fully vest and be treated as set forth
in Section&nbsp;3.02(c) of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a Qualifying Termination during a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period, all tranches of Equity
Awards with a vesting date within 12 months after your Date of Termination will fully vest. In addition, for a Qualifying Termination during a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period, any vesting tranche of Equity Awards that began
during your employment or during the first 12 months after your Date of Termination but was not completed by the first anniversary of your Date of Termination shall vest pro rata based </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on a fraction, the numerator of which is the number of months within such vesting tranche you would have been employed if you had remained employed through the first anniversary of your Date of
Termination, and the denominator of which is the total number of months in the vesting tranche, or, for performance-based Equity Awards, the total number of months in the performance period. For the avoidance of any doubt: (i)&nbsp;the payout for
performance-based Equity Awards for a Qualifying Termination during a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period will be based on actual performance during the entire performance period, then
<FONT STYLE="white-space:nowrap">pro-rated</FONT> as noted above; and (ii)&nbsp;the provisions of this paragraph shall supersede the provisions contained in the applicable Equity Awards Agreements, provided that the provisions of the Equity Award
Agreements will control to the extent such provisions are more favorable to you. Examples of the application of this paragraph regarding vesting with respect to a Qualifying Termination during a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period
are set forth in Exhibit A and are deemed to be a part of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For you, the definition of &#147;Good Reason&#148; in Section&nbsp;1.01(dd)(i)
of the Plan is deleted and shall be replaced in its entirety by the following: &#147;a material reduction of the Participant&#146;s authority, job duties or responsibilities including the assignment to the Participant of any duties materially and
negatively inconsistent in respect of the Participant&#146;s position (including status, offices, titles and reporting requirements), or any other action by the Company which results in a material diminution in such position, authority, duties or
responsibilities;&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, by executing this Agreement, you acknowledge and agree that your participation in the Plan is in consideration for your
strict compliance with the restrictive covenants in Article&nbsp;VI of the Plan, which include covenants for best efforts, <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> and <FONT
STYLE="white-space:nowrap">non-disclosure</FONT> of Confidential Information applicable regardless of whether you actually receive termination benefits under the Plan and that any termination benefits that you may become entitled to receive under
the Plan will be subject to your strict compliance with each restrictive covenant in Article&nbsp;VI of the Plan for the duration of the Restricted Period. The length of the Restricted Period depends on when your Date of Termination occurs, as
follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Timing of Date of Termination</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Length&nbsp;of&nbsp;Restricted&nbsp;Period</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date of Termination during a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">12&nbsp;months</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date of Termination during a CIC Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">24 months</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By executing this Agreement and participating in the Plan, you acknowledge and agree that as set forth in Section&nbsp;2.03 of
the Plan, the Plan does not intend to duplicate severance benefits. Accordingly, the severance payments and benefits under this Agreement and the Plan to you shall be reduced by any severance benefits to which you would otherwise be entitled under
any offer letter or employment agreement or other agreement you have with the Company or any severance policy or plan maintained by the Company that provides for severance benefits. Likewise, the severance payments and benefits to which you are
otherwise entitled under this Agreement and the Plan shall be reduced by any payments or benefits to which you may be entitled under plant-closing or mandatory severance or garden leave or similar laws of any applicable jurisdiction. By executing
this Agreement, you also acknowledge and agree that if you previously signed a Participation Agreement with respect to the Plan, this Participation Agreement supersedes and replaces any such prior Participation Agreement with respect to the Plan.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You acknowledge that you have carefully read this Agreement including, without limitation, the restrictive
covenants set forth in Article VI of the Plan and incorporated herein and consulted with legal counsel of your choosing regarding its contents, have given careful consideration to the restraints imposed upon you by the Plan and this Agreement,
including, without limitation, Article VI of the Plan and are in full accord as to their necessity for the reasonable and proper protection of confidential and proprietary information of the Company now existing or to be developed in the future. You
acknowledge that you have consulted with counsel and are individually represented in negotiating the terms of this Agreement, which incorporates the section of the Plan designating the choice of law to be applied hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You understand, acknowledge and agree that (i)&nbsp;you have no obligation to enter into this Agreement or become a Participant in the Plan and your decision
to do so by signing this Agreement is knowing and voluntary; and (ii)&nbsp;agreeing to the restrictive covenants contained in Article VI of the Plan is not a condition of employment and the continuation of your employment will not depend on whether
you agree to the restrictive covenants in Article VI of the Plan. The agreement to the restrictive covenants in Article VI of the Plan is in consideration of your eligibility for the Plan. You acknowledge and agree that you were represented by
counsel in connection with the negotiation of this Agreement, including without limitation the specific negotiation of the restrictive covenants in Article VI of the Plan and governing law in Section&nbsp;8.07 of the Plan. You acknowledge that the
Company is incorporated in Pennsylvania and its principal executive offices are in Pennsylvania. You also acknowledge and agree that you will be subject to restrictive covenants, governing law, and dispute provisions set forth in the Plan, to which
you shall be bound in all respects. You further acknowledge and agree that pursuant to Section&nbsp;925 of the California Labor Code, (i)&nbsp;you have waived the application of California law to this Agreement and the Plan, including without
limitation, the restrictive covenants contained in Article VI of the Plan, and any proceeding related thereto, (ii)&nbsp;you have waived any right to have any proceeding adjudicated in California, and (iii)&nbsp;you acknowledge and agree that any
proceeding shall not be deemed to be a controversy arising in California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has executed this Agreement by its duly
authorized officer as of the date set forth below. Please sign below and return this Agreement to the Company by no later than [DATE]. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">[PARTICIPANT NAME]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">COHERENT CORP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signed:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that I represented <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> individually as legal
counsel in negotiating the terms of this Agreement including, without limitation, the incorporation of the restrictive covenants in Section VI of the Plan and governing law in Section&nbsp;8.07 of the Plan. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attorney&nbsp;Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">]</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXAMPLES OF EQUITY VESTING IN CONNECTION WITH QUALIFYING </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION IN A <FONT STYLE="white-space:nowrap">NON-CIC</FONT> PERIOD </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Example 1</U></B>:&#8201;&#8195;<B>TIME</B><B><FONT STYLE="white-space:nowrap">-BASED</FONT> RSUS WITH ANNUAL VESTING</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">August&nbsp;30, 2023 3,600 RSU grant with annual vesting &#150; 1/3 (1,200 RSUs) vesting each year &#150; August&nbsp;30, 2024,
August&nbsp;30, 2025 and August&nbsp;30, 2026 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2024 Date of Termination </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">12 month additional service credit for vesting </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">August&nbsp;30, 2024 vesting of the first tranche of 1,200 RSUs: within 12 months of Date of Termination so such 1,200 RSUs vest </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">August&nbsp;30, 2025 vesting of second tranche of 1,200 RSUs: 12 months since Separation Date is June&nbsp;30, 2025 &#150; 10 months into the
vesting tranche that began August&nbsp;31, 2024 and ends August&nbsp;30, 2025 (a 12 month vesting tranche) &#150; so 10/12 of such 1,200 RSU tranche means 1,000 RSUs vest </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">August&nbsp;30, 2026 vesting tranche of 1,200 RSUs: tranche began August&nbsp;31, 2025 which is more than 12 months after the Date of
Termination of June&nbsp;30, 2024 and therefore no vesting of any RSUs in this tranche </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Example 2</U></B>:&#8194;&#8195;<B>TIME</B><B><FONT STYLE="white-space:nowrap">-BASED</FONT> RSUS WITH
CLIFF VESTING</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">August&nbsp;30, 2023 2,400 RSU grant with <FONT STYLE="white-space:nowrap">2-year</FONT> (24 months) cliff vesting
&#150; vesting of entire award on August&nbsp;30, 2025 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2024 Date of Termination </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">12 month additional service credit for vesting </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">No vesting date by June&nbsp;30, 2025 &#150; 12 months after Date of Termination </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2025 is 22 months into the 24 month cliff vesting period so 22/24 of such 2,400 RSU tranche means 2,200 RSUs vest </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Example 3</U></B>:&#8194;&#8195;<B>PERFORMANCE SHARE UNIT AWARD WITH CLIFF VESTING</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">August&nbsp;30, 2023 3,600 target PSU grant cliff vesting at June&nbsp;30, 2026 based on performance for the 3 year (36 month) performance
period from July&nbsp;1, 2023 to June&nbsp;30, 2026 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2024 Date of Termination </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">12 month additional service credit for vesting </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">No vesting date by June&nbsp;30, 2025 &#150; 12 months after Date of Termination </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">June&nbsp;30, 2025 is 24 months into the 36 month cliff performance period ending June&nbsp;30, 2026 so 24/36 of such PSU that would have been
earned based on performance through June&nbsp;30, 2026 vests </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">If PSUs earned as a percent of target PSU grant based on performance is
determined after June&nbsp;30, 2026 to be 90%, then </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">The PSUs that vest would be 3,600 (target award) multiplied by 90% (performance)
multiplied by 24/36 <FONT STYLE="white-space:nowrap">(pro-ration)</FONT> which equals 2,160&nbsp;PSUs </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">Such 2,160 PSUs (based on
performance and proration) would be distributed after the certification of performance for the <FONT STYLE="white-space:nowrap">3-year</FONT> performance period ending June&nbsp;30, 2026 </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Annex A: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COHERENT
CORP. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REVISED EXECUTIVE SEVERANCE PLAN </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g888602g1010084511512.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COHERENT CORP., 375 Saxonburg Boulevard, Saxonburg, PA 16056 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">General Offices: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">724-352-4455</FONT></FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COHERENT CORP. REVISED EXECUTIVE SEVERANCE PLAN </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the Coherent Corp. Revised Executive Severance Plan (as amended and in effect from time to time, the &#147;<U>Plan</U>&#148;),
is to enhance the Company&#146;s ability to retain designated key executives. The Plan is intended to be a severance pay plan governed by Title I of ERISA primarily for the purpose of providing benefits for a select group of management or highly
compensated employees. All benefits under the Plan will be paid solely from the general assets of the Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section
1.01&#8195;Definitions</U>. As used in this Plan, the following terms have the meanings set forth below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;&#147;<U>Accounting
Firm</U>&#148; has the meaning set forth in Section&nbsp;7.02. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;&#147;<U>Accrued Obligations</U>&#148; means vested amounts
payable to a Participant upon any termination of employment with the Company, including (i)&nbsp;the Participant&#146;s earned but unpaid Base Salary from the Company through the Date of Termination, (ii)&nbsp;any outstanding Bonus for which payment
is due and owing as of the Date of Termination, (iii)&nbsp;any vested employee benefits as determined under the applicable plan, and (iv)&nbsp;any unreimbursed expenses properly incurred and reported by the Participant in accordance with the
Company&#146;s business expense reimbursement policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;&#147;<U>Affiliate</U>&#148; means, with respect to any individual or
entity, any other individual or entity who, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with, such individual or entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;&#147;<U>Applicable Benefits Multiplier</U>&#148; means a multiplier (expressed as a number of months) contained in a
Participant&#146;s Revised Participation Agreement that is used to determine a Participant&#146;s termination benefits under Sections&nbsp;3.01(b) and 3.02(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195;&#147;<U>Applicable Bonus Multiplier</U>&#148; means the multiplier contained in a Participant&#146;s Revised Participation
Agreement that is used to determine the portion of the Participant&#146;s termination benefits described in Section&nbsp;3.02(a)(B). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&#8195;&#147;<U>Applicable Protection Period</U>&#148; means the period (expressed as a number of months) contained in a Participant&#146;s
Participant Agreement that is used to determine the CIC Period applicable to the Participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&#8195;&#147;<U>Applicable Severance Multiplier</U>&#148; means the multiplier (expressed
as a number of months) contained in a Participant&#146;s Revised Participation Agreement that is used to determine the portion of the Participant&#146;s termination benefits described in Sections&nbsp;3.01(a) and 3.02(a)(A). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&#8195;&#147;<U>Base Salary</U>&#148; means a Participant&#146;s annual salary for all services rendered as in effect at the time a benefit
under the Plan is calculated; provided, however, that in case of a Qualifying Termination as the result of Good Reason triggered by a reduction in Base Salary, &#147;Base Salary&#148; shall mean the Participant&#146;s annual salary as in effect
immediately before the event giving rise to Good Reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;&#147;<U>Board</U>&#148; means the Board of Directors of the Corporate
Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&#8195;&#147;<U>Bonus,</U>&#148; at the time that a benefit under the Plan is calculated, means the bonus(es) payable to a
Participant pursuant to the Company&#146;s BIP, GRIP or other incentive bonus plan that is in effect at such time. For this purpose, the &#147;<U>BIP</U>&#148; means the Company&#146;s Bonus Incentive Program and the &#147;<U>GRIP</U>&#148; means
the Company&#146;s Goals/Results Incentive Program, in each case as such program may be amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&#8195;&#147;<U>Cause</U>&#148; means a determination by the Board, in the exercise of its reasonable judgment, that any of the following
has occurred with respect to a particular Participant: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;the Participant&#146;s willful and continued failure
before a Change in Control to perform substantially the Participant&#146;s employment duties and responsibilities (other than a failure resulting from physical or mental illness or disability), which is not cured within 30&nbsp;days of receiving
written notice from the Company specifying in reasonable detail the duties and responsibilities the Company believes are not being substantially performed; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;the Participant willfully engaged in an act which is materially damaging to the Company (which damage may, without
limitation, include reputational damage); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&#8195;the Participant was convicted of, or entered a plea of
&#147;guilty&#148; or &#147;no contest&#148; to: (A)&nbsp;a felony; or (B)&nbsp;a criminal offense involving fraud, dishonesty or other moral turpitude; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&#8195;the Participant materially breached any of the covenants set forth in Article VI and if the breach occurs after a
Change in Control is not cured within 30 days of receiving written notice from the Company specifying in reasonable detail the breach of the covenant set forth in Article VI; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&#8195;the Participant engaged in an intentional act of dishonesty resulting, directly or indirectly, in material damage to
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the Company to terminate for Cause on or after a Change in Control: the Participant must be provided with written notice
setting forth in detail the acts or omissions giving rise to such termination and must be given an opportunity to address the Board regarding the termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&#8195;&#147;<U>Change in Control</U>&#148; means any of the following events that occurs
after the Effective Date: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;the Corporate Parent is merged or consolidated with another entity the result of which
is that immediately following such transaction (A)&nbsp;the persons who were the shareholders of the Corporate Parent immediately prior to such transaction have less than a majority of the voting power of the Corporate Parent or the entity owning or
controlling it; or (B)&nbsp;the individuals who comprised the Board immediately prior to such transaction cease to be at least a majority of the members of the Board; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;a majority of the Corporate Parent&#146;s assets are sold or otherwise transferred to another corporation not
controlled by or under common control with the Corporate Parent, or to a partnership, firm, entity or one or more individuals not so controlled; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&#8195;a majority of the members of the Board consists of persons who were not nominated by or on behalf of the Board, or
with the express concurrence of the Board; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&#8195;a single person, or a group of persons acting in concert, obtains
voting control over a majority of the Corporate Parent&#146;s outstanding voting shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&#8195;&#147;<U>CIC Period</U>&#148; means
the period commencing on the date six months prior to a Change in Control and ending on a date that is at the end of the Participant&#146;s Applicable Protection Period following the Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&#8195;&#147;<U>CIC Period Bonus</U>&#148; means, the greater of (i)&nbsp;Bonus at target (A)&nbsp;for the performance period in which the
Change in Control occurs (or for the immediately preceding performance period if the target payment with respect to the Participant for the performance period in which the Change in Control occurs has not yet been established) (without regard to any
reduction made in the target payment within the six month period prior to the Change in Control) or (B)&nbsp;for the performance period in which the Participant&#146;s Date of Termination occurs, whichever target payment is highest and
(ii)&nbsp;Bonus based on performance (A)&nbsp;for the performance period in which the Change in Control occurs (but not less than that projected as of the Change in Control if the performance period has not been completed as of the Change in
Control), or (B)&nbsp;for the performance period in which the Participant&#146;s Date of Termination occurs, whichever performance payment is highest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&#8195;&#147;<U>Code</U>&#148; means the U.S. Internal Revenue Code of 1986, as amended (including any valid and binding governmental
regulations, court decisions and other regulatory and judicial authority issued or rendered thereunder). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)&#8195;&#147;<U>Company</U>&#148; means, collectively, the Corporate Parent and its Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q)&#8195;&#147;<U>Company Products</U>&#148; means any products or services (i)&nbsp;designed, manufactured, purchased, distributed, sold,
assembled, provided and/or marketed by the Company, or (ii)&nbsp;that the Company has planned to design, manufacture, purchase, distribute, sell, assemble, provide or market, and for which a Participant has provided services, or over which a
Participant had direct </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or indirect managerial or supervisory authority, or about which a Participant received Confidential Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r)&#8195;&#147;<U>Compensation and Human Capital Committee</U>&#148; means the Compensation and Human Capital Committee of the Board or any
successor committee dealing with compensation . </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s)&#8195;&#147;<U>Competitor</U>&#148; means any entity that is involved or engaged in
the design, manufacture, purchasing, distribution, sale, assembly, provision or marketing of any products or services that are the same as or similar to Company Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t)&#8195;&#147;<U>Confidential Information</U>&#148; has the meaning set forth in Section&nbsp;6.02(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u)&#8195;&#147;<U>Corporate Parent</U>&#148; means Coherent Corp., a Pennsylvania corporation, and any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&#8195;&#147;<U>Date of Termination</U>&#148; means the date on which a Participant&#146;s employment with the Company terminates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w)&#8195;&#147;<U>Disability</U>&#148; means a Participant&#146;s physical or mental illness, injury or infirmity which is reasonably likely
to prevent and/or prevents the Participant from performing his or her essential job functions for a period of (A)&nbsp;90 consecutive calendar days or (B)&nbsp;an aggregate of 120 calendar days out of any consecutive
<FONT STYLE="white-space:nowrap">12-month</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&#8195;&#147;<U>Effective Date</U>&#148; means September&nbsp;24, 2019 as the
original effective date of the Plan and November&nbsp;16, 2023 as the effective date of this revised Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y)&#8195;&#147;<U>Eligible
Executive</U>&#148; means a full-time employee of the Company who has been designated by the Plan Administrator to be eligible for benefits under the Plan. Eligible Executives shall be limited to a select group of management or highly compensated
employees within the meaning of ERISA Sections&nbsp;201, 301, and 404. Unless the Plan Administrator determines otherwise, the Company&#146;s Chief Executive Officer shall not be an Eligible Executive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z)&#8195;&#147;<U>Equity Award</U>&#148; means an award granted to a Participant covering the common stock of the Company, including stock
options, restricted stock, restricted stock units, and performance stock units, granted under any equity incentive plan maintained by the Company from time to time, including: (i)&nbsp;the <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated
2009 Omnibus Incentive Plan, (ii)&nbsp;the II-VI Incorporated Second Amended and Restated 2012 Omnibus Incentive Plan, (iii)&nbsp;the <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated Amended and Restated 2018 Omnibus Incentive Plan,
(iv)&nbsp;the Coherent, Inc. Equity Incentive Plan (v)&nbsp;the Coherent Corp. Omnibus Incentive Plan or (vi)&nbsp;any successor plan(s) thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa)&#8195;&#147;<U>Equity Award Agreement</U>&#148; means the agreement evidencing, and governing the terms of, an Equity Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb)&#8195;&#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc)&#8195;&#147;<U>Excise Tax</U>&#148; has the meaning set forth in Section&nbsp;7.01. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd)&#8195;&#147;<U>Good Reason</U>&#148; means, without a Participant&#146;s express
written consent: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;a material reduction of the Participant&#146;s authority, job duties or responsibilities,
provided however that, before a Change in Control, a change in reporting structure only, which results in additional levels of supervision and/or management above the Participant, shall not constitute Good Reason; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;a material reduction by the Company of the Participant&#146;s Base Salary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&#8195;a material increase in the amount of the Participant&#146;s business travel which produces a constructive
relocation of the Participant; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&#8195;a material reduction by the Company in the kind or level of employee benefits to
which the Participant is entitled immediately prior to such reduction, with the result that the Participant&#146;s overall benefits package is significantly reduced; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&#8195;the relocation of the Participant to a facility or a location more than 30 miles from the Participant&#146;s Primary
Work Location, unless such relocation results in the Participant&#146;s primary work location being closer to the Participant&#146;s then primary residence, or does not substantially increase the average commuting time of the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a Participant to terminate for Good Reason: the Company must be notified by the Participant in writing within 90&nbsp;days of the event
constituting Good Reason; the event must remain uncorrected by the Company for 30&nbsp;days following such notice (the &#147;Notice Period&#148;); and such termination must occur within 60&nbsp;days after the expiration of the Notice Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee)&#8195;&#147;<U>Healthcare Coverage</U>&#148; means coverage for a Participant and his or her
<FONT STYLE="white-space:nowrap">tax-qualified</FONT> dependents under the Company&#146;s group health plan that provides medical care (including group dental and vision), based on the applicable plans and the Participant&#146;s coverage elections
in effect immediately prior to the Participant&#146;s Date of Termination. The Company&#146;s group health plan does not include other benefits offered under a Company welfare plan such as life insurance and disability insurance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff)&#8195;&#147;<U>Inventions</U>&#148; means any and all developments, discoveries, inventions, enhancements, modifications and improvements
by the Participant to any Company Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg)&#8195;&#147;<U><FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period</U>&#148; means the
period prior to or following a CIC Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh)&#8195;&#147;<U>Nonqualifying Termination</U>&#148; means a termination of the
Participant&#146;s employment with the Company other than a Qualifying Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;&#147;<U>Participant</U>&#148; means each
Eligible Executive who is selected to be a participant in the Plan by action of the Plan Administrator and who has accepted such participation by execution of a Participation Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj)&#8195;&#147;<U>Payments</U>&#148; has the meaning set forth in Section&nbsp;7.01. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk)&#8195;&#147;<U>Plan Administrator</U>&#148; means the Compensation and Human Capital
Committee, or, if the Board so determines, another committee of the Board, or the Board itself. To the extent permitted by applicable law, the Plan Administrator may delegate all or any portion of its authority to one or more officers of the Company
or a committee consisting of at least two persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll)&#8195;&#147;<U>Primary Work Location</U>&#148; means the primary work location
for a Participant as set forth in the Participant&#146;s Participation Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm)&#8195;&#147;<U>Qualifying Termination</U>&#148;
means a (i)&nbsp;termination of the Participant&#146;s employment with the Company by the Company other than for Cause, death or Disability, or (ii)&nbsp;termination of the Participant&#146;s employment with the Company as a result of a resignation
by the Participant for Good Reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn)&#8195;&#147;<U>Release</U>&#148; means the waiver and release of claims substantially in the
form attached hereto as Exhibit&nbsp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo)&#8195;&#147;<U>Restricted Period</U>&#148; means the period beginning on a
Participant&#146;s Date of Termination and continuing for the number of months following the Date of Termination as specified in the Participant&#146;s Participation Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(pp)&#8195;&#147;<U>Restricted Territory</U>&#148; means anywhere in the world where the Company&#146;s Products are designed, manufactured,
assembled, marketed or sold. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qq)&#8195;&#147;<U>Revised Participation Agreement</U>&#148; means the latest participation agreement
delivered by the Company to a Participant informing the Eligible Employee of the Eligible Employee&#146;s participation in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rr)&#8195;&#147;<U>Separation from Service</U>&#148; means a &#147;separation from service&#148; within the meaning of Code
Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ss)&#8195;&#147;<U>Target Bonus Amount</U>&#148; means, with respect to any Year, the amount of the target Bonus for
such Year (including under both the BIP and the GRIP, if applicable). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(tt)&#8195;&#147;<U>Year</U>&#148; means the fiscal year of the
Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PARTICIPATION AND SCOPE OF SEVERANCE BENEFITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;2.01&#8195;Participation in the Plan</U>. An Eligible Executive shall become a Participant only if the Eligible Executive is
first designated for participation in the Plan as follows: (i)&nbsp;for an Eligible Executive who is an officer subject to Section&nbsp;16(a) of the Securities Exchange Act of 1934, as amended, the Eligible Executive must be designated for
participation in the Plan by the Compensation Committee; and (ii)&nbsp;for any other Eligible Executive, the Eligible Executive must be designated for participation in the Plan by the Chief Executive Officer of the Corporate Parent. Promptly
following such designation, the Company shall provide each Participant a Revised Participation Agreement, which shall specify the benefits the Participant is entitled to receive under the Plan. The party making the eligibility determination
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under the first sentence of this Section may vary the terms of a Participant&#146;s participation on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT>
basis, as set forth in the Participant&#146;s Revised Participation Agreement. A designated Eligible Executive shall not become a Participant unless and until the Revised Participation Agreement is duly executed. Once participation in the Plan has
commenced, a Participant shall remain a Participant until the first to occur of (i)&nbsp;the Participant&#146;s Nonqualifying Termination, (ii)&nbsp;the completion of the delivery of all benefits under the Plan following a Qualifying Termination
under circumstances giving rise to a right to such benefits, or (iii)&nbsp;termination of the Plan prior to a Qualifying Termination as provided in Section&nbsp;5.01. For avoidance of doubt, the rights and obligations of the Company and of an
Eligible Executive who does not execute a Revised Participation Agreement, but who had previously executed a participation agreement under a prior Executive Severance Plan, shall be governed by such prior participation agreement and Executive
Severance Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;2.02&#8195;Conditions</U>. As a condition precedent to entitlement of each Participant to benefits under
Sections&nbsp;3.01 and 3.02 of the Plan, the Participant agrees to each of the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;The Participant shall have executed,
within 21&nbsp;days, or if required for an effective release, 45&nbsp;days, following the Participant&#146;s Date of Termination, the Release, and the applicable revocation period set forth in such release shall have expired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;The Participant agrees to execute a resignation letter stating that, effective as of the Participant&#146;s Date of Termination, or
such earlier date as required or requested by the Company, the Participant resigns from all positions with the Company, whether as an employee, an officer, a director or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;The Participant shall reaffirm his or her agreement to abide by the covenants set forth in Article VI. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 2.03&#8195;No Duty to Mitigate; <FONT STYLE="white-space:nowrap">Non-duplication</FONT></U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;A Participant shall not be required to mitigate the amount of any payment or benefit provided for in the Plan by seeking other
employment or otherwise, and no such payment or benefit shall be offset or reduced by the amount of any compensation or benefits provided to the Participant in any subsequent employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;The Company does not intend to duplicate severance benefits. Accordingly, the severance payments and benefits under the Plan to a
Participant shall be reduced by any severance benefits to which the Participant would otherwise be entitled under the Participant&#146;s offer letter or employment agreement with the Company (if applicable), or any general severance policy or plan
maintained by the Company that provides for severance benefits (unless the agreement, policy or plan expressly provides for severance benefits to be in addition to those provided under the Plan). The severance payments and benefits to which a
Participant is otherwise entitled shall be further reduced (but not below zero) by any payments or benefits to which the Participant may be entitled under any federal, state or local plant-closing (or similar or analogous) laws or mandatory
severance benefits under the laws of any other applicable jurisdiction. Any such reductions or offsets in severance benefits shall be made in a manner that complies with Code Section&nbsp;409A (if applicable). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION BENEFITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 3.01&#8195;Qualifying Termination During a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period</U>. If a Participant incurs a
Qualifying Termination and his or her Date of Termination is during a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period, then, in addition to any Accrued Obligations, the Participant shall be entitled to the following (which shall be payable in
accordance with Article&nbsp;IV): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Cash Severance</U>. An amount equal to the product of (i)&nbsp;the Participant&#146;s
Applicable Severance Multiplier, and (ii)&nbsp;the Participant&#146;s monthly rate of Base Salary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Healthcare Coverage
Payment</U>. An amount equal to the product of (i)&nbsp;the Participant&#146;s Applicable Benefits Multiplier and (ii)&nbsp;the full total monthly premium cost (<I>i.e.</I>, the Participant&#146;s and the Company&#146;s portion) for the
Participant&#146;s Healthcare Coverage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 3.02&#8195;Qualifying Termination During a CIC Period</U>. If a Participant incurs a
Qualifying Termination and his or her Date of Termination is during a CIC Period, then, in addition to any Accrued Obligations, the Participant shall be entitled to the following (which shall be payable in accordance with Article&nbsp;IV): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Cash Severance</U>. An amount equal to (A)&nbsp;the product of (i)&nbsp;the Participant&#146;s Applicable Severance Multiplier
and (ii)&nbsp;the Participant&#146;s monthly rate of Base Salary, plus (B)&nbsp;the product of (i)&nbsp;the Participant&#146;s Applicable Bonus Multiplier and (ii)&nbsp;the Participant&#146;s Target Bonus Amount for the Year in which the Date of
Termination occurs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Healthcare Coverage Payment</U>. An amount equal to the product of (i)&nbsp;the Participant&#146;s
Applicable Benefits Multiplier and (ii)&nbsp;the full total monthly premium cost (i.e., the Participant&#146;s and the Company&#146;s portion) for the Participant&#146;s Healthcare Coverage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;<U>Equity Vesting</U>. Any unvested Equity Awards will become fully vested and, if applicable, each such Equity Award shall remain
exercisable for the period set forth in the applicable Equity Awards Agreement. For the avoidance of any doubt, the provisions of this Section&nbsp;3.02(c) shall supersede the provisions contained in the applicable Equity Awards Agreements, provided
that the provisions of the Equity Award Agreements will control to the extent such provisions are more favorable to the Participant. In the case of any performance-based Equity Awards, &#147;full vesting&#148; means vesting based on the level of
performance adjustment determined under the terms of the applicable Equity Award Agreement in connection with the Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195; <U><FONT STYLE="white-space:nowrap">Pro-Rata</FONT> Bonus</U>. An amount equal to a pro rata portion (based on the number of days
during the applicable performance year Participant was employed by the Company) of the Participant&#146;s CIC Period Bonus. In addition, if the Bonus for the performance year immediately preceding the Participant&#146;s Date of Termination had not
yet been paid, the Participant shall receive 100% of the Bonus, if any, for such immediately preceding performance period that would otherwise have been paid to Participant (without the application of any negative discretion) if Participant&#146;s
employment had not so terminated, payable at the same time as such Bonus is paid to other Company employees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM AND TIME OF PAYMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 4.01&#8195;Payments for a Qualifying Termination During a <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Period</U>. The amount
contemplated under Section&nbsp;3.01(a) shall be paid in accordance with the Company&#146;s regular pay schedule in substantially equal installments over a period equal to a Participant&#146;s Applicable Severance Multiplier following the
Participant&#146;s Date of Termination. The amount contemplated under Section&nbsp;3.01(b) shall be paid in a lump sum cash in the next pay period after the Release becomes effective (not more than 75 days after the Participant&#146;s Date of
Termination). In both cases, the payments described shall be conditioned on the Participant providing the Company with (and not revoking) a Release, no later than 60&nbsp;days after the Participant&#146;s Date of Termination. Any payments will
commence in the next pay period after the Release becomes effective (not more than 75&nbsp;days after the Participant&#146;s Date of Termination), including a lump sum for any payments for any payroll periods from the Date of Termination through the
date the Release becomes effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 4.02&#8195;Payments for a Qualifying Termination During a CIC Period</U>. The amounts
contemplated under Section&nbsp;3.02(a) and Section&nbsp;3.02(b) shall be paid in a lump sum cash payment in the next pay period after the Release becomes effective (not more than 75 days after the Participant&#146;s Date of Termination). The amount
of the CIC Period Bonus based on those portions of the formula that are knowable at such time shall be paid in a lump sum cash payment in the next pay period after the Release becomes effective (not more than 75 days after the Participant&#146;s
Date of Termination) and if the CIC Period Bonus is determined to be greater when the other portions of the formula for the CIC Period Bonus are known, such excess amount shall be paid in a lump sum cash payment within ten (10)&nbsp;days after such
determination. The amount of the Bonus set forth in the second sentence of Section&nbsp;3.02(d) shall be paid at the later of (i)&nbsp;in the next pay period after the Release becomes effective (not more than 75 days after the Participant&#146;s
Date of Termination) or (ii)&nbsp;at the same time as such Bonus is paid to other Company employees. The payments described in each of Section&nbsp;3.02(a), Section&nbsp;3.02(b) and Section&nbsp;3.02(d) shall be conditioned on the Participant
providing the Company with (and not revoking) a Release, no later than 60&nbsp;days after the Participant&#146;s Date of Termination. Vesting of Equity Awards under Section&nbsp;3.02(c) shall also be conditioned on the Participant providing, and not
revoking, the Release within 60&nbsp;days following the Date of Termination. Payment of any restricted stock units as a result of such vesting shall be made no later than 75&nbsp;days following the Date of Termination, subject to compliance with the
requirements of Code Section&nbsp;409A. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT / TERMINATION OF PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 5.01&#8195;Plan Amendment and Termination</U>. This Plan may be amended or terminated by action of the Board; provided, however,
that any amendment or termination that reduces or eliminates potential termination benefits under Article&nbsp;III for a Participant shall not, without the Participant&#146;s prior written consent: (i)&nbsp;be effective for any Qualifying
Termination until one year after notice is provided to the Participant; and (ii)&nbsp;be effective until after the end of the applicable CIC Period if a Change in Control occurs while this Plan is in effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section
6.01&#8195;Full Time, Best Efforts and Conduct</U>. Each Participant covenants and agrees to devote all of the Participant&#146;s business time and efforts to the faithful performance of the duties assigned to the Participant from time to time by
the Company, except to the extent that the Company expressly permits the Participant to engage in outside activities during business hours. The Company and the Participant acknowledge that, from time to time, the Participant may either desire or be
asked by the Company to engage in business activities or perform business services for the benefit of third parties, such as, e.g., serving as an outside director or consultant for another company. In each case, the Participant&#146;s involvement in
such business activities or services shall be subject to the mutual agreement and approval of both the Company and the Participant. The Participant shall at all times engage in conduct in accordance with the highest standards of ethics and shall
take no action that will harm the reputation of the Company. To every extent not inconsistent with the terms of this Agreement, the terms and conditions of the Participant&#146;s employment are also governed by the Company&#146;s personnel policies
and employee handbook, as they may be issued and amended from time to time </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 6.02&#8195;Confidential Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Nondisclosure and <FONT STYLE="white-space:nowrap">Non-Use</FONT></U>. Both during the term of a Participant&#146;s employment
with Company and thereafter, the Participant covenants and agrees that the Participant (i)&nbsp;shall exercise the utmost diligence to protect and safeguard the Confidential Information of the Company; (ii)&nbsp;shall not disclose to any third party
any Confidential Information, except as may be required by the Company in the course of the Participant&#146;s employment or by law; and (iii)&nbsp;shall not use Confidential Information except for the benefit of the Company. The Participant
acknowledges that Confidential Information has been and will be developed and acquired by the Company by means of substantial expense and effort, that the Confidential Information is a valuable proprietary asset of the Company&#146;s business, and
that its disclosure would cause substantial and irreparable injury to the Company&#146;s business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Definition of
Confidential Information</U>. &#147;<U>Confidential Information</U>&#148; means all information of a confidential or proprietary nature, whether or not specifically labeled or identified as &#147;confidential,&#148; in any form or medium, that is or
was disclosed to, or developed or learned by, the Participant in connection with the Participant&#146;s past, present or future employment with the Company and that relates to the business, products, services, research or development of any of the
Company or its suppliers, distributors or customers. Confidential Information includes, but is not limited to, the following: (i)&nbsp;internal business information (including, but not limited to, information relating to strategic plans and
practices, business, training, marketing, promotional and sales plans and practices, cost, rate and pricing structures, accounting and business methods); (ii)&nbsp;identities of, individual requirements of, specific contractual arrangements with,
and information about, any of the Company&#146;s suppliers, distributors and customers and their confidential information; (iii)&nbsp;trade secrets, <FONT STYLE="white-space:nowrap">know-how,</FONT> compilations of data and analyses, techniques,
systems, formulae, research, records, reports, manuals, documentation, models, data and data bases relating thereto; (iv)&nbsp;inventions, innovations, improvements, developments, methods, designs, analyses, drawings, reports and all similar or
related information (whether or not patentable); and (v)&nbsp;other information or thing that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has economic value, actual or potential, from not being generally known to or not being readily ascertainable by proper means by other persons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;<U>Not Confidential Information</U>. Confidential Information shall not include information that the Participant can demonstrate:
(i)&nbsp;is publicly known through no wrongful act or breach of obligation of confidentiality by the Participant; (ii)&nbsp;was rightfully received by the Participant from a third party without a breach of any obligation of confidentiality by such
third party; or (iii)&nbsp;was known to the Participant on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis prior to the Participant&#146;s employment with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;<U>Presumption of Confidentiality</U>. In any judicial proceeding, it will be presumed that the Confidential Information constitutes
protectable trade secrets and the Participant will bear the burden of proving that any Confidential Information is publicly or rightfully known by the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195;<U>Return of Confidential Information and Materials</U>. Each Participant agrees to return to the Company either before or
immediately upon the termination of the Participant&#146;s employment with the Company any and all information, materials or equipment which constitutes, contains or in any way relates to the Confidential Information and any other document,
equipment or materials of any kind relating in any way to the business of the Company in the possession, custody or control of the Participant which was obtained by the Participant during the course of or as a result of the Participant&#146;s
employment with the Company, whether confidential or not, including, but without limitation, any copies thereof which may have been made by or for the Participant. The Participant shall also provide the Company, if requested to do so, the name of
the new employer of the Participant and the Company shall have the right to advise any subsequent employer of the Participant&#146;s obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 6.03&#8195;Inventions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Ownership of Inventions</U>. Any and all Inventions created or developed by a Participant alone or with others during the term of
the Participant&#146;s employment, whether or not during working hours and whether on the Company&#146;s premises or elsewhere, shall be deemed works for hire and will be the sole and exclusive property of the Company if the Invention is: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;within the scope of the Participant&#146;s duties assigned or implied in accordance with the Participant&#146;s
position; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;a product, service, or other item which would be in competition with Company Products or which is
related to Company Products, whether presently existing, under development, or under active consideration; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&#8195;in whole or in part, the result of the Participant&#146;s use of the Company&#146;s resources, including, without
limitation, personnel, computers, equipment, facilities or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Assignment of Inventions</U>. Each Participant shall
promptly and fully disclose all Inventions to the Company and shall cooperate and perform all actions reasonably requested by the Company to establish, confirm and protect the Company&#146;s right, title and interest in each
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Invention. During the term of the Participant&#146;s employment with the Company and after termination of such employment, if the Company should then so request, the Participant agrees to
assign and does hereby assign to the Company all rights in the Inventions. The Participant agrees to execute and deliver to the Company any instruments the Company deems necessary to vest in the Company all title to and rights in the Inventions
which the Participant is legally authorized to grant. The Participant agrees to execute and deliver to the Company all proper papers for use in applying for, obtaining, maintaining, amending and enforcing any legal protections that the Company may
desire. The Participant further agrees to assist fully the Company or its nominees in the preparation and prosecution of any litigation connected with the Inventions. If the Company is unable because of the Participant&#146;s mental or physical
incapacity or for any other reason (including, but without limitation, the Participant&#146;s refusal to do so after request therefor is made by the Company) to secure the Participant&#146;s signature to apply for or to pursue any application for
any United States or foreign patents or copyright registrations covering Inventions belonging to or assigned to the Company pursuant to this Agreement, then the Participant hereby irrevocably designates and appoints the Company and its duly
authorized officers and agents as the Participant&#146;s agent and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> to act for and on the Participant&#146;s behalf and stead to execute and file any
such applications and to do all other lawfully permitted acts to further the prosecution and issuance of patents or copyright registrations thereon with the same legal force and effect as if executed by the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 6.04&#8195;Non-Competition</U>. Each Participant covenants and agrees that, during the term of the Participant&#146;s employment
with the Company and the Restricted Period, the Participant shall not, directly or indirectly, for the benefit of the Participant or others, as an employee, principal, agent, stockholder, consultant, or in any other capacity, (i)&nbsp;work for a
Competitor; or (ii)&nbsp;have a financial interest in any Competitor, within the Restricted Territory. Notwithstanding the foregoing, nothing herein shall prohibit the Participant from being a passive owner of not more than 5% of the outstanding
securities of any class of a corporation which is publicly traded, so long as the Participant has no active participation in the business of any such corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This covenant on the part of the Participant shall be construed as an agreement independent of any other provision of this Plan or applicable
Participation Agreement; and the existence of any claim or cause of action of the Participant against the Company, whether predicated on this Plan, Participation Agreement, or otherwise, shall not constitute a defense to the enforcement by the
Company of this covenant. The Participant expressly agrees that the restrictions of this Article VI will not prevent the Participant from otherwise obtaining gainful employment upon termination of the Participant&#146;s employment with the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 6.05&#8195;Non-Solicitation of Business Associates</U>. During the Restricted Period, the Participant shall not directly or
indirectly induce, solicit or encourage any customer, supplier or other business associate of the Company to terminate or alter its relationship with the Company, or introduce, offer or sell, to or for any customer or business associate, any
products or services that compete with the Company Products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 6.06&#8195;Non-Solicitation of Employees</U>. During the
Restricted Period, no Participant shall, directly or indirectly, induce, solicit or encourage any employee of the Company to terminate or alter his or her relationship with the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FEDERAL EXCISE TAX UNDER SECTION 4999 OF THE CODE IN CONNECTION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WITH A CHANGE IN CONTROL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 7.01&#8195;Adjustments to Payments</U>. Anything in this Plan to the contrary notwithstanding, if (a)&nbsp;it is determined that
any payment or distribution by the Company to the Participant or for the Participant&#146;s benefit (whether paid or payable or distributed or distributable pursuant to the terms of this Plan or otherwise) (the &#147;<U>Payments</U>&#148;) would be
subject to the excise tax imposed by Section&nbsp;4999 (or any successor provisions) of the Code, or (b)&nbsp;any interest or penalty is incurred by the Participant with respect to such excise tax (such excise tax, together with any such interest
and penalties, is hereinafter collectively referred to as the &#147;<U>Excise Tax</U>&#148;), then the Payments shall be reduced (but not below zero) if and to the extent that such reduction would result in the Participant retaining a larger amount,
on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis (taking into account federal, state and local income taxes and the imposition of the Excise Tax), than if the Participant received all of the Payments. The Company shall reduce or
eliminate the Payments by first reducing or eliminating the portion of the Payments which are not payable in cash and then by reducing or eliminating cash payments, in each case in reverse order beginning with payments or benefits which are to be
paid the farthest in time from the determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 7.02&#8195;Determinations</U>. All determinations required to be made under
this Article&nbsp;VII, including whether and when an adjustment to any Payments is required and, if applicable, which Payments are to be so adjusted, shall be made by an independent accounting firm selected by the Company from among the four largest
accounting firms in the United States or any nationally recognized financial planning and benefits consulting company (the &#147;<U>Accounting Firm</U>&#148;) which shall provide detailed supporting calculations both to the Company and the
applicable Participant at such time as may be requested by the Company, or earlier within 15 business days of the receipt of notice from the Participant that there has been a Payment. If the Accounting Firm that the Company selects is serving as
accountant or auditor for the individual, entity or group effecting the Change in Control, the Company shall appoint another nationally recognized accounting firm to make the determinations required hereunder (which accounting firm shall then be
referred to as the Accounting Firm hereunder). All fees and expenses of the Accounting Firm shall be borne solely by the Company. If the Accounting Firm determines that no Excise Tax is payable by a Participant, it shall furnish the Participant with
a written opinion that failure to report the Excise Tax on the Participant&#146;s applicable federal income tax return would not result in the imposition of a negligence or similar penalty. Any determination by the Accounting Firm shall be binding
upon the Company and the Participant. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS PROVISIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 8.01&#8195;Plan Administration</U>. The Plan Administrator shall administer the Plan and may interpret the Plan, prescribe, amend
and rescind rules and regulations under the Plan and make all other determinations necessary or advisable for the administration of the Plan, subject to all of the provisions of the Plan. The Plan Administrator is empowered, on behalf of the Plan,
to engage accountants, legal counsel and such other personnel as it deems necessary or advisable to assist it in the performance of its duties under the Plan. The functions of any such persons engaged by the Plan Administrator will be limited to the
specified services and duties for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which they are engaged, and such persons will have no other duties, obligations or responsibilities under the Plan. Such persons will exercise no discretionary authority or discretionary control
respecting the management of the Plan. All reasonable expenses thereof will be borne by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 8.02&#8195;Withholding
Taxes</U>. The Company may withhold from all payments due to the Participant (or his beneficiary or estate) hereunder all taxes which, by applicable federal, state, local or other law, the Company is required to withhold. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 8.03&#8195;Successors&#146; Binding Obligation</U>. The Plan will be binding upon any successor to the Corporate Parent, its
assets, its businesses or its interest (whether as a result of the occurrence of a Change in Control or otherwise), in the same manner and to the same extent that the Corporate Parent would be obligated under the Plan if no succession had taken
place. In the case of any transaction in which a successor would not by the foregoing provision or by operation of law be bound by the Plan, the Corporate Parent shall require any successor to the Corporate Parent to expressly and unconditionally
assume the Plan in writing and honor the obligations of the Corporate Parent and any applicable Affiliates hereunder, in the same manner and to the same extent that the Corporate Parent and such Affiliates would be required to perform if no
succession had taken place. All payments and benefits that become due to a Participant under the Plan will inure to the benefit of his or her heirs, assigns, designees or legal representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 8.04&#8195;No Assignment or Transfer; Beneficiaries; Unfunded Obligations</U>. Except as otherwise determined by the Plan
Administrator, benefits payable under this Plan shall not be assignable or transferable by the Participant, and shall not be subject in any manner to assignment, alienation, pledge, encumbrance or charge. Notwithstanding the foregoing, in the event
of the death of a Participant, except as otherwise provided by the Plan Administrator, benefits earned but unpaid under this Plan shall become payable to the Participant&#146;s beneficiary as designated by the Participant in the manner prescribed by
the Plan Administrator or, in the absence of an authorized beneficiary designation, by a legatee or legatees of the Participant&#146;s Plan benefit under the Participant&#146;s last will or by such Participant&#146;s executors, personal
representatives or distributees of such Plan benefit in accordance with the Participant&#146;s will or the laws of descent and distribution. The amounts to be paid to Participants under the Plan are unfunded obligations of the Company. The Company
is not required to segregate any monies or other assets from its general funds with respect to these obligations. Participants shall not have any preference or security interest in any assets of the Company other than as a general unsecured
creditor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 8.05&#8195;Compensation Recoupment</U>. All awards, amounts or benefits received or outstanding under this Plan
shall be subject to clawback, cancellation, recoupment, rescission, payback, reduction or other similar action in accordance with any Company clawback or similar policy or any applicable law related to such actions. Each Participant shall be deemed
to have acknowledged and consented to the Company&#146;s application, implementation and enforcement of any applicable Company clawback or similar policy that may apply to the Participant, whether adopted before or after the Effective Date, and any
applicable law relating to clawback, cancellation, recoupment, rescission, payback, or reduction of compensation, and the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may take any actions that may be necessary to effectuate any such policy or applicable law, without further consideration or action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 8.06&#8195;Notice</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;For purposes of this Plan, all notices and other communications required or permitted hereunder shall be in writing and shall be
deemed to have been duly given when received if delivered by hand, recognized expedited courier service, or email, postage and other fees prepaid, addressed as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Participant: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">To the
most recent address or email address of the Participant set forth in the personnel records of the Company </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">Coherent Corp. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">5000 Ericsson
Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">Warrendale, PA 15806 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">Attention: Chief Legal Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">Email: Legal.Notices@coherent.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">or to such other address as either party may have furnished to the other in writing in accordance herewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;A written notice of the Participant&#146;s Date of Termination by the Company or the Participant, as the case may be, to the other,
shall (i)&nbsp;indicate the specific termination provision in this Plan relied upon, (ii)&nbsp;to the extent applicable, set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Participant&#146;s
employment under the provision so indicated, and (iii)&nbsp;specify the Date of Termination. In the case of a termination by the Company other than a termination for Cause, the Date of Termination shall not be less than 30&nbsp;days after the notice
of termination is given. In the case of a termination by the Participant, the Date of Termination shall be the date that the cure period contemplated under Section&nbsp;1.01(dd) has expired if the Company has failed to remedy within such period the
circumstances constituting Good Reason. The failure by the Participant or the Company to set forth in such notice any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Participant or the
Company, or preclude the Participant or the Company, from asserting such fact or circumstance in enforcing the Participant&#146;s or the Company&#146;s rights hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 8.07&#8195;Governing Law; Validity</U>. The interpretation, construction and performance of the provisions of this Plan shall be
governed by and construed and enforced in accordance with the internal laws of the Commonwealth of Pennsylvania without regard to conflicts of law principles, to the extent Pennsylvania laws are not preempted by ERISA. The invalidity or
unenforceability of any provision of this Plan shall not affect the validity or enforceability of any other provision of this Plan, which other provisions shall remain in full force and effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 8.08&#8195;Waiver</U>. No provision of this Plan may be waived unless such waiver
is agreed to in writing and signed by the Participant and by a duly authorized officer of the Company. No waiver by one party of the other party&#146;s of a breach of, or failure to comply with, a condition or provision of this Plan shall be deemed
a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. Failure by the Participant or the Company to insist upon strict compliance with any provision of this Plan or to assert any right the
Participant or the Company may have hereunder, including without limitation, the right of the Participant to terminate employment for Good Reason, shall not be deemed to be a waiver of such provision or right, or of any other provision or right.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 8.09&#8195;Code Section 409A</U>. Notwithstanding any provision of the Plan to the contrary, the Plan and any payments
provided hereunder are intended to comply with, or be exempt from, Code Section&nbsp;409A. The Plan shall in all respects be interpreted, operated, and administered in accordance with this intent. Payments provided under the Plan may only be made
upon an event and in a manner that complies with Code Section&nbsp;409A or an applicable exemption, including, to the maximum extent possible, exemptions for separation pay due to Separation from Service and/or short-term deferrals. Any payments
provided under the Plan to be made upon a Participant&#146;s termination of employment with the Company that constitute deferred compensation subject to Code Section&nbsp;409A shall only be made if such termination of service constitutes a
Separation from Service. Each installment payment provided under the Plan shall be treated as a separate identified payment for purposes of Code Section&nbsp;409A. The Company makes no representations or warranties that the payments provided under
the Plan comply with, or are exempt from, Code Section&nbsp;409A, and in no event shall the Company be liable for any portion of any taxes, penalties, interest, or other expenses that may be incurred by a Participant on account of <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with Code Section&nbsp;409A. If a Participant is a &#147;specified employee&#148; under Code Section&nbsp;409A at his or her Date of Termination, to the extent necessary to avoid the imposition of any
additional taxes under Code Section&nbsp;409A, any payments to be made upon the Participant&#146;s Separation from Service that constitute deferred compensation subject to Code Section&nbsp;409A and that are scheduled to be made within six months
following the Participant&#146;s Date of Termination shall be delayed, without interest, and paid in a lump sum on the earlier of (i)&nbsp;the first payroll date to occur following the six month anniversary of the Participant&#146;s Date of
Termination, or (ii)&nbsp;the Participant&#146;s death, and any payments otherwise scheduled to be made thereafter shall be made in accordance with their original schedule. Notwithstanding any provision of the Plan to the contrary, if any payments
to a Participant to be made under the Plan are subject to Code Section&nbsp;409A and the period during which the Participant may sign the Release begins in one calendar year and the first payroll period following the end of the period during which
the Participant may sign the Release occurs in the following calendar year, then such payments shall not be made or commence until the commencement of such following calendar year but no later than 75 Days after the Participant&#146;s Date of
Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 8.10&#8195;No Right to Continued Employment</U>. Neither the establishment of the Plan, nor any modification of
it, and no creation of any fund, trust or account, or payment of any benefits, will be construed as giving any Participant, or any other person, the right to be retained in the service of the Company, and all Participants will remain subject to
discharge to the same extent as if the Plan had never been adopted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;8.11</U><U>&#8195;</U><U>Attorney Fees for Enforcement in
Connection with CIC Period Termination</U>. For a Participant whose Date of Termination occurs within the CIC Period, the Company shall pay on behalf of or reimburse to Participant promptly (in no event later than 30 days after the invoice date) all
reasonable costs and expenses (including fees and disbursements of counsel) incurred by such Participant in seeking to enforce rights pursuant to this Plan, whether or not such Participant is successful in asserting such rights; provided, however,
that no reimbursement shall be made of such expenses relating to any unsuccessful assertion of rights if and to the extent that Participant&#146;s assertion of such rights was in bad faith. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CLAIMS,
INQUIRIES, APPEALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 9.01&#8195;Applications for Benefits and Inquiries</U>. Any application for benefits, inquiries about
the Plan, and inquiries about present or future rights under the Plan must be submitted to the Plan Administrator in writing, addressed to the Company in accordance with the notice provisions set forth in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 9.02&#8195;Denial of Claims</U>. If any application for benefits is denied in whole or in part, the Plan Administrator must notify
the applicant, in writing, of the denial, and of the applicant&#146;s right to review the denial. The written notice of denial will be set forth in a manner designed to be understood by the Participant, and will include specific reasons for the
denial, specific references to the Plan provision upon which the denial is based, a description of any information or material that the Plan Administrator needs in order to complete the review, and an explanation of the Plan&#146;s review procedure.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This written notice will be given to the Participant within 30&nbsp;days after the Plan Administrator receives the application, unless
special circumstances require an extension of time, in which case, the Plan Administrator has up to an additional 30&nbsp;days for processing the application. If an extension of time for processing is required, written notice of the extension will
be furnished to the applicant before the end of the initial 30&nbsp;day period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This notice of extension will describe the special
circumstances necessitating the additional time and the date by which the Plan Administrator is to render his or her decision. If written notice of denial of the application for benefits is not furnished within the specified time, the application
will be deemed to be denied. The applicant will then be permitted to appeal the denial in accordance with the review procedure described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 9.03&#8195;Request for a Review</U>. Any person (or that person&#146;s authorized representative) for whom an application for
benefits is denied (or deemed denied), in whole or in part, may (but is not required to) appeal the denial by submitting a request for a review to the Plan Administrator within 60&nbsp;days after the application is denied (or deemed denied). The
Plan Administrator will give the applicant (or his or her representative) an opportunity to review pertinent documents in preparing a request for a review. A request for a review must be in writing and addressed to the Company in accordance with the
notice provisions set forth in the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A request for review must set forth all of the grounds on which it is based, all facts in
support of the request, and any other matters that the applicant feels are pertinent. The Plan Administrator may require the applicant to submit additional facts, documents or other material the Plan Administrator deems necessary or appropriate in
connection with his or her review. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 9.04&#8195;Decision on Review</U>. The Plan Administrator will act on each request for
review within 20&nbsp;days after receipt of the request, unless special circumstances require an extension of time (not to exceed an additional 20&nbsp;days). If an extension for review is required, written notice of the extension will be furnished
to the applicant within the initial <FONT STYLE="white-space:nowrap">20-day</FONT> period. The Plan Administrator will give prompt, written notice of his or her decision to the applicant. If the Plan Administrator confirms the denial of the
application for benefits in whole or in part, the notice will outline, in a manner calculated to be understood by the applicant, the specific Plan provisions on which the decision is based. If written notice of the Plan Administrator&#146;s decision
is not given to the applicant within the time prescribed in this Section&nbsp;9.04, the application will be deemed denied on review. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 9.05&#8195;Rules and Procedures</U>. The Plan Administrator may establish rules and procedures, consistent with the Plan and with
ERISA, that are necessary or appropriate in carrying out his or her responsibilities in reviewing benefit claims. The Plan Administrator may require an applicant who wishes to submit additional information in connection with an appeal to do so at
the applicant&#146;s own expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 9.06&#8195;Exhaustion of Remedies</U>. No claim for benefits under the Plan may be brought
in any forum until the claimant (a)&nbsp;has submitted a written application for benefits in accordance with the procedures described by Section&nbsp;9.01, (b)&nbsp;has been notified by the Plan Administrator that the application is denied (or the
application is deemed denied due to the claims administrator&#146;s failure to act within the established time period), (c)&nbsp;has filed a written request for a review of the application in accordance with the appeal procedure described in
Section&nbsp;9.03, and (d)&nbsp;has been notified in writing that the Plan Administrator has denied the appeal (or the appeal is deemed to be denied under Section&nbsp;9.04). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section 9.07&#8195;Final Dispute Resolution; Limitations on Legal Action</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>General</U>. Except as provided in Section&nbsp;9.07(c) below, all claims and disputes under this Plan (including but not limited
to claims and disputes regarding interpretation, scope, or validity of the Plan, and any pendant state claims not preempted by ERISA) must follow the claims procedures described in Sections&nbsp;9.01 through 9.06, before a claimant may take action
in any other forum regarding a claim for benefits under the Plan. Any action initiated by a claimant under the Plan must be brought within one year of a final determination on the claim, or the claim will be deemed permanently waived and abandoned,
and the claimant will be precluded from reasserting it. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Claims for Benefits</U>. After following the claims procedures
described in Sections&nbsp;9.01 through 9.06, the following provisions apply to any further disputes, claims, questions or disagreements that may arise regarding this Plan. Except to the extent set forth in Section&nbsp;9.07(c), any such dispute
shall be finally settled by arbitration conducted expeditiously in accordance with the rules of the American Arbitration Association by three independent and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
impartial arbitrators. Each party shall appoint one arbitrator, and the two arbitrators so appointed shall appoint the third. The arbitration shall be conducted in English, and shall be governed
by the United States Arbitration Act, 9 U.S.C. &#167;&#167; <FONT STYLE="white-space:nowrap">1-16,</FONT> and judgment on the award rendered by the arbitrators may be entered by any court having jurisdiction. The place of arbitration shall be
Pittsburgh, Pennsylvania. The arbitrators are not empowered to award damages in excess of economic and compensatory damages. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;<U>Injunctive Relief</U>. Notwithstanding any provision in the Plan to the contrary, if a Participant violates a covenant contained
in Article VI and the Company would be caused immediate, material and irreparable harm for which money damages might not be adequate compensation, the Company shall be entitled to injunctive or other equitable relief in addition to any other
remedies provided by law, in equity or otherwise. The Restricted Period applicable to the Participant shall be extended by any period of time in which the Participant is in breach of the covenants contained in Article VI and for any period of time
necessary to secure an order of court or injunction, either temporary or permanent, to enforce any of the covenants contained in Article VI. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GENERAL RELEASE AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This General Release Agreement (this &#147;Agreement&#148;) is made and entered into by
<U><B>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</B></U> (&#147;Executive&#148; or &#147;Your&#148; or &#147;Your&#148;) (collectively, referred to in this Agreement as &#147;<B>Executive</B>&#148;) and <B>Coherent
Corp.</B>, any parent, subsidiary, affiliate, successor, predecessor or otherwise related companies, and the past, present, and future employees, agents, officers, attorneys, directors, shareholders, members, managers and executive benefit programs
of any of them, and their agents and insurers (collectively, referred to in this Agreement as the &#147;<B>Company</B>&#148;). This Agreement shall become effective upon the signing of this Agreement by You or, if applicable, as defined in
Section&nbsp;9.2 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration of the severance pay and benefits provided to Executive as set forth in the Coherent Corp.
Executive Severance Plan (the &#147;Severance Plan&#148;), as well as any promises set forth in this Agreement, Executive agrees as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.0&#8195;<B>Release of Claims</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1&#8195;In exchange for the Company providing You with the payments and other benefits set forth in the Severance Plan, You, and Your spouse,
attorneys, heirs, dependents, beneficiaries, executors, administrators, successors, and assigns, hereby unconditionally release and completely and forever discharge the Company, on behalf of and for the benefit of itself, all related corporate
entities and partnerships, and each of their past, present and future employees, officers, directors, attorneys, owners, partners, members, insurers, benefit plan fiduciaries and agents, and all of their respective successors and assigns
(&#147;<I><U>Released Parties</U></I>&#148;), from any and all rights, claims, causes of action, or lawsuits whether known or unknown, that you ever had, now have, or may have against any or all of the Released Parties up to the date of execution of
this Agreement including, without limitation, any and all claims you had, have, or may have arising out of or relating to your employment with the Company or the separation of that employment, for any and all reasons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You specifically release Released Parties from any rights or claims that you may have based upon the Employee Retirement Income Security Act,
Title VII of the Civil Rights Act of 1964, the Americans With Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Equal Pay Act, the Family and Medical Leave Act, Sections&nbsp;1981 through 1988 of U.S.C. Title 42, all as
amended, and any rules or regulations under such laws and authorities; all Pennsylvania employment discrimination laws, including but not limited to the Pennsylvania Human Relations Act; the Pennsylvania Equal Pay Act; the Pennsylvania Minimum Wage
Act; the Pennsylvania Wage Payment and Collection Law; Pennsylvania statutes regarding whistleblower protection, personnel Files, criminal records, wage complaints, retaliation; all as amended together with all of their respective implementing
regulations; and/or any other federal, state or local laws or regulations prohibiting employment discrimination or which otherwise regulate employment terms and conditions. You also release the Released Parties from any claim for negligence,
wrongful discharge, unfair treatment, defamation, breach of public policy, express or implied contract, or any other claims arising under common law that relate in any way to your employment with the Company or the termination thereof. The foregoing
description of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
claims is intended to be illustrative and is not exhaustive. The Parties intend this release to be a release of any and all claims to the fullest extent permissible under law. This waiver and
release is of Your rights to all remedies and damages available to You in law or equity, including but not limited to Your right to compensation, backpay, front pay, <FONT STYLE="white-space:nowrap">non-economic</FONT> damages, punitive and
exemplary damages, statutory damages, attorneys&#146; fees, injunctive relief and declaratory judgments. This general release does not extend to claims which You do not know or suspect exist at the time of executing the release, which if known by
You would have materially affected Your entering into this Agreement with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2&#8195;Notwithstanding the release contained in
Section&nbsp;1.1, You do not waive (i)&nbsp;Your entitlement to receive any 401(k), pension plan benefits, or Company ERISA-covered benefits that shall have vested (if any) as of the date You sign this Agreement to the extent You have any
entitlement to those benefits under the terms of the relevant plans, or (ii)&nbsp;Your right to file a charge with the EEOC or participate in an investigation conducted by the EEOC; however, You expressly waive Your right to monetary or other relief
should any administrative agency, including but not limited to the EEOC, pursue any claim on Your behalf. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3&#8195;The release contained
in Section&nbsp;1.1 above does not apply to any claim or rights that may arise after that date You sign this Agreement or claims that the controlling law clearly states may not be released by private agreement. You also understand that You are not
waiving Your rights to unemployment compensation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.0&#8195;<B>Covenant Not to Sue</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1&#8195;You warrant that You do not have any complaint, charge or grievance against any Released Party pending before any federal, state or
local court or administrative or arbitral agency, and You further covenant not to sue, file a lawsuit, or commence any other proceeding, arbitral, administrative or judicial action, against any of the Released Parties in any court of law or equity,
or before any arbitral body or administrative agency, with respect to any matter released in Section&nbsp;1.1 above; provided, however, that this covenant not to sue does not affect Your rights to enforce appropriately the terms of the Severance
Plan in a court of competent jurisdiction and does not affect Your right to file a charge with the EEOC or participate in an investigation conducted by the EEOC; however, You expressly waive Your right to monetary or other relief should any
administrative agency, including but not limited to the EEOC, pursue any claim on Your behalf. Notwithstanding the foregoing, nothing herein shall limit Your right to receive an award for information provided to the Securities and Exchange
Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nothing in this Agreement prohibits You from reporting possible violations of federal law or regulation to any governmental agency or entity,
including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or making other disclosures that are protected under the whistleblower provisions of federal law or
regulation. You do not need the prior authorization of the Company to make any such reports or disclosures and You are not required to notify the Company that You have made such reports or disclosures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2&#8195;Should You file a lawsuit with any court concerning any claim, demand, issue, or cause of action waived, released or discharged
through this Agreement or otherwise in breach of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;2.1 above, You agree (i)&nbsp;that any amounts payable or paid to You, as applicable, pursuant to Section&nbsp;2 of the Severance Plan shall no longer be payable and, if already
paid, shall promptly be returned to the Company and (ii)&nbsp;to the fullest extent allowed by applicable law, to indemnify the Released Parties for all costs and expenses incurred by them in defending such lawsuit. You further agree that nothing in
this Agreement shall limit the right of a court to determine, in its sole discretion, that the Released Parties are entitled to restitution, recoupment or set off of any monies paid should the release of any claims under this Agreement subsequently
be found to be invalid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3&#8195;You agree not to advocate or incite the institution of, or assist or participate in, any suit, unrest,
complaint, charge or administrative proceeding by any other person against any of the Released Parties, unless compelled by legal process to do so. Nothing in this Section&nbsp;2 shall prohibit any Party from lawfully participating or cooperating in
an investigative proceeding of any federal, state or local government agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.0&#8195;<B><FONT STYLE="white-space:nowrap">Non-Admission</FONT> of
Liability</B>. You agree that this Agreement shall not in any way be construed as an admission that any of the Released Parties owe You any money or have acted wrongfully, unlawfully, or unfairly in any way towards You. In fact, You understand that
the Released Parties specifically deny that they have violated any federal, state or local law or ordinance or any right or obligation that they owe or might have owed to You at any time, and maintain that they have at all times treated You in a
fair, <FONT STYLE="white-space:nowrap">non-discriminatory</FONT> and <FONT STYLE="white-space:nowrap">non-retaliatory</FONT> manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.0&#8195;<B>Confidentiality of Agreement</B>. You also acknowledge and agree that You shall not publicize, communicate, authorize or permit the publication
or communication in any form whatsoever of the contents of this Agreement or the events giving rise thereto, except to Your immediate family, Your financial advisors and/or legal counsel, or where required by law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.0&#8195;<B>Representations and Indemnification</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1&#8195;You represent to the company that You will abide by any and all post-employment restrictive covenants You signed or entered into in
connection with Your employment, including but not limited to, covenants relating to competition, solicitation or hiring of employees, solicitation of customers, and confidentiality. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2&#8195;You agree that You will indemnify and hold the Released Parties harmless from any loss, cost, damage or expense (including
attorneys&#146; fees) incurred by the Released Parties arising out of Your breach of any portion of this Agreement or any post-employment restrictive covenant You signed or entered into in connection with Your employment. You also agree and
understand that Your entitlement to and retention of the Severance Benefits the Company has agreed to provide to You are expressly conditioned upon Your fulfillment of Your promises herein and any applicable post-employment restrictive covenants,
and You agree that if You breach this Agreement or any applicable post-employment restrictive covenants that any amounts payable or paid to You, as applicable, pursuant to the Severance Plan, shall no longer be payable and, if already paid, shall
promptly be returned to the Company within seven days of the Company providing you with written notice of Your breach of any provision of this Agreement or any applicable post-employment restrictive covenants, to the extent permitted or required by
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
law. The Company shall determine whether a breach has occurred in its sole discretion and under any applicable law or regulation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.0&#8195;<B>Miscellaneous</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1&#8195;<I>Governing Law and Venue</I>. This Agreement and all things relating or pertaining to it shall be governed by, and construed in
accordance with, the laws of the Commonwealth of Pennsylvania, without reference to conflict of laws principles. Any action relating to this Agreement must be instituted in the courts of Butler County, Pennsylvania, or the federal courts of the
Western District of Pennsylvania. The Company and Employee hereby consent to the jurisdiction of such courts and waive any right or defense relating to venue or jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2&#8195;<I>Severability</I>. Whenever possible, each provision of this Agreement shall be interpreted so as to be effective and valid under
applicable law, but if any of its provisions is prohibited by or invalid under such law, such provision shall be ineffective to the extent of such prohibition or invalidity, and severed from this Agreement without invalidating any other part of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3&#8195;<I>Proper Construction</I>. The language of this Agreement shall be construed within the context of the whole
Agreement and according to its fair meaning, and not strictly for or against either the Parties. The section headings used in this Agreement are intended solely for convenience of reference and shall not in any manner amplify, limit, modify or
otherwise be used in its interpretation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4&#8195;<I>Survival</I>. You acknowledge that the covenants in the Severance Plan, and any
provisions contained in the Severance Plan that are intended to survive following termination of Your employment, shall survive the execution of this Agreement by You. You further acknowledge that any and all post-employment restrictive covenants
You signed in connection with Your employment, including covenants relating to competition, solicitation or hiring, and agreements not to compete, remain in full force and effect, and a breach of those covenants or agreements will also constitute a
breach of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5&#8195;<I>Amendments</I>. This Agreement may be modified, altered or terminated only by an express written
agreement between You and the Company, that is signed by both parties, and to which a copy of this Agreement is attached. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.6&#8195;<I>Counterparts</I>. This Agreement may be signed in counterparts, which together shall be treated as one document. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.0&#8195;<B>Acknowledgment</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1&#8195;You
confirm that, to the best of Your knowledge, You have returned to the Company all of its property, including without limitation, computer equipment, software, keys and access cards, credit cards, files and any documents (including computerized data
and any copies made of computerized data or software) containing information concerning the Company, its business or its business relationships. You also commit to deleting and finally purging any duplicates of files or documents that contain the
Company information from any computer or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other device that remains Your property after the Termination Date, provided such information is not subject to an ongoing litigation hold. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2&#8195;You acknowledge that, if you are age 40 or over, You have had 21&nbsp;days, or if required for an effective release, 45&nbsp;days,
after receipt of this Agreement (and Appendix&nbsp;A if required to be attached hereto) to consider whether to execute it, and you understand all the provisions of this agreement. You also understand that, after you execute this Agreement, you have
seven days to revoke the portion of this Agreement that relates to waiver and release of any claim you might assert under the Age Discrimination in Employment Act (&#147;ADEA&#148;). The parties agree that no payment set forth in the Severance Plan
will be made until after the seven day revocation period has expired (the eighth day after You execute this Agreement being the &#147;Effective Date&#148; of this Agreement for those age 40 or over). You understand that, by signing this Agreement,
You are not waiving or releasing any ADEA claims based on actions or omissions that occur after the date You sign. You agree that any revocation of Your ADEA waiver and release must be made in writing and postmarked on or before the seventh day
following the execution of this Agreement and sent by certified mail to the respective company contact at the addresses set forth in Section&nbsp;8.06 of the Severance Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3&#8195;With the exception of any payments and other benefits set forth in the Severance Plan or any signed retention bonus agreement, and
of your final paycheck (to include Your regular wages and any accrued but unused vacation or other paid time off to be delivered by the next regularly scheduled payday or otherwise as required by law), You acknowledge payment of all compensation due
to You by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4&#8195;You acknowledge that You have been advised in writing, and hereby are advised, to seek legal counsel
concerning the terms of this Agreement. You warrant that you have read this Agreement, are knowingly and voluntarily entering into it and intend to be legally bound by it, and that your agreement to it is not the result of coercion or duress by the
Company. You certify and agree that you are authorized and competent to sign this Agreement, and that you are receiving valuable and adequate consideration under it. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BY SIGNING BELOW, YOU ACKNOWLEDGE THAT (1)&nbsp;YOU HAVE CAREFULLY READ AND CONSIDERED THIS AGREEMENT; (2)&nbsp;HAVE BEEN GIVEN SUFFICIENT TIME TO CONSIDER
WHETHER TO SIGN IT; (3)&nbsp;RECOGNIZE AND UNDERSTAND THAT IT CONTAINS A FULL AND FINAL RELEASE BY YOU OF ALL CLAIMS OF EVERY KIND AGAINST THE COMPANY ARISING UP TO THE TIME YOU SIGN IT, WHETHER YOU CURRENTLY KNOW OR SUSPECT THOSE CLAIMS TO EXIST;
AND (4)&nbsp;KNOWINGLY AND VOLUNTARILY CONSENT TO THE TERMS OF THIS AGREEMENT WITH FULL UNDERSTANDING OF THEIR MEANING. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Executive has executed this General Release Agreement as of the date set
forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>EXECUTIVE</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Received, Acknowledged and Accepted:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>COHERENT CORP.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">[Name, Title]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Exhibit II to Sherri Luther Offer Letter </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEMNIFICATION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This AGREEMENT (this &#147;<U>Agreement</U>&#148;) is made as of October&nbsp;11, 2024, between Coherent Corp., a Pennsylvania corporation
(the &#147;<U>Company</U>&#148;), and Sherri R. Luther (&#147;<U>Indemnitee</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, it is essential to the Company to retain
and attract as directors and officers the most capable persons available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Indemnitee is a director and/or officer and/or agent
of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, both the Company and Indemnitee recognize the increased risk of litigation and other claims being asserted
against directors, officers, and agents of public companies in today&#146;s environment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, basic protection against undue risk of
personal liability of directors and officers heretofore has been provided through insurance coverage providing reasonable protection at reasonable cost, and Indemnitee has relied on the availability of such coverage; but as a result of substantial
changes in the marketplace for such insurance it has become increasingly more difficult to obtain such insurance on terms providing reasonable protection at reasonable cost. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Pennsylvania Business Corporation Law, as amended (the &#147;PBCL&#148;), and the Amended and Restated <FONT
STYLE="white-space:nowrap">By-Laws</FONT> of the Company (the &#147;Bylaws&#148;) expressly provide that the indemnification and advancement of expenses provisions set forth therein are not exclusive of any other rights to which those seeking
indemnification or advancement of expenses may be entitled under, among other things, any agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of
the Company has determined that the inability of the Company to retain and attract as directors, officers, and agents the most capable persons would be detrimental to the interests of the Company and that the Company therefore should seek to assure
such persons that indemnification and insurance coverage will be available in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in recognition of Indemnitee&#146;s
need for substantial protection against personal liability in order to enhance Indemnitee&#146;s service to the Company in an effective manner and Indemnitee&#146;s reliance on the Company&#146;s Amended and Restated Articles of Incorporation (the
&#147;Charter&#148;) and Bylaws, and in part to provide Indemnitee with specific contractual assurance that the protection promised by such Charter and Bylaws will be available to Indemnitee (regardless of, among other things, any amendment to or
revocation of such Charter or Bylaws or any change in the composition of the Company&#146;s Board of Directors or acquisition transaction relating to the Company), the Company wishes to provide in this Agreement for the indemnification of and the
advancing of expenses to Indemnitee to the fullest extent (whether partial or complete) permitted by law and as set forth in this Agreement, and, to the extent insurance is maintained, for the continued coverage of Indemnitee under the
Company&#146;s directors&#146; and officers&#146; liability insurance policies; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Bylaws and the PBCL expressly provide that the indemnification provisions set
forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the board of directors, officers, and other persons with respect to indemnification; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and of Indemnitee continuing to serve the Company directly or, at its request, another
enterprise, and intending to be legally bound hereby, the parties hereto agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&#8195;&#8195;<U>Services to the
Company</U>. Indemnitee will serve, or continue to serve, at the will of the Company in accordance with the Bylaws, as an officer and/or director and/or agent of the Company for so long as Indemnitee is duly elected or appointed or until Indemnitee
tenders his resignation; <U>provided</U>, <U>however</U>, that nothing herein is intended to modify or alter the rights and obligations of the Company and Indemnitee under any terms of employment or employment agreement or arrangement between the
Company and Indemnitee that is now in effect or that hereafter comes into effect, nor shall anything herein guaranty a right to employment or board membership. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&#8195;&#8195;<U>Certain Definitions</U>. In addition to terms defined elsewhere herein, the following terms have the following meanings
when used in this Agreement: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;&#8195;<U>Corporate Status</U>: describes a person who is or was serving as a director, officer,
employee, trustee, agent, or fiduciary of the Company, or is or was serving at the request of the Company as a director, officer, employee, trustee, agent, or fiduciary of another corporation, limited liability company, partnership, joint venture,
employee benefit plan, trust, or other entity or enterprise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;&#8195;<U>Disinterested Director</U>: means a director of the
Company who is not and was not a party to the Claim in respect of which indemnification is sought by Indemnitee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;&#8195;<U>Change in Control</U>: shall be deemed to have occurred if (i)&nbsp;any &#147;person&#148; (as such term is used in
Sections 13(d) and 14(d) of the Exchange Act), other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company or a corporation owned directly or indirectly by the stockholders of the Company in substantially
the same proportions as their ownership of stock of the Company, is or becomes the &#147;<U>Beneficial Owner</U>&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act), directly or indirectly, of securities
of the Company representing 20% or more of the total voting power represented by the Company&#146;s then outstanding Voting Securities, or (ii)&nbsp;during any period of two consecutive years, individuals who at the beginning of such period
constitute the Board of Directors of the Company and any new director whose election by the Board of Directors or nomination for election by the Company&#146;s stockholders was approved by a vote of at least
<FONT STYLE="white-space:nowrap">two-thirds</FONT> (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to
constitute a majority thereof, or (iii)&nbsp;the stockholders of the Company approve a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in the Voting Securities of the Company
outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into Voting </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities of the surviving entity) at least 80% of the total voting power represented by the Voting Securities of the Company or such surviving entity outstanding immediately after such merger
or consolidation, or the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of (in one transaction or a series of transactions) all or substantially all the
Company&#146;s assets, or (iv)&nbsp;there occurs any other event of a nature that would be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the
Exchange Act, whether or not the Company is then subject to such reporting requirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;<U>Claim</U>: means any threatened,
asserted, pending, or completed issue, matter, action, suit, or proceeding, or any inquiry or investigation, whether instituted by the Company or any governmental agency or any other party, that Indemnitee in good faith believes might lead to the
institution of any such issue, matter, action, suit, or proceeding, whether civil, criminal, administrative, investigative, or other, including any arbitration or other alternative dispute resolution mechanism. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&#8195;<U>Exchange Act</U>: means the Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&#8195;<U>Expenses</U>: include attorneys&#146; fees and all other costs, expenses, and obligations (including, without
limitation, experts&#146; fees, travel expenses, court costs, retainers, transcript costs, duplicating, printing and binding costs, as well as telecommunications, postage, and courier charges) paid, payable, or incurred, by or on behalf of the
Indemnitee, in connection with investigating, defending, being a witness in, or participating in (including on appeal), or preparing to investigate, defend, be a witness in, or participate in, any Claim relating to any Indemnifiable Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&#8195;<U>Indemnifiable Amounts</U>: means any and all Expenses, damages, judgments, fines, penalties, ERISA or other excise taxes, and
amounts paid or payable in settlement (including all interest, assessments, and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties, excise taxes, or amounts paid in settlement) arising out of
or resulting from any Claim relating to an Indemnifiable Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&#8195;<U>Indemnifiable Event</U>: means any event or occurrence,
whether occurring before or after the date of this Agreement, related to Indemnitee&#146;s Corporate Status, or by reason of anything done or not done by Indemnitee in any such capacity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&#8195;<U>Independent Legal Counsel</U>: means a law firm, or a member of a law firm, that is experienced in matters of corporation law and
neither is, nor in the past five (5)&nbsp;years has been, retained to represent: (i)&nbsp;the Company or Indemnitee in any matter material to any such party (other than with respect to matters concerning the Indemnitee under this Agreement, or of
other indemnities under similar indemnification agreements), (ii) any other party to the Claim for indemnification hereunder, or (iii)&nbsp;the Beneficial Owner, directly or indirectly, of securities of the Company representing 5% or more of the
combined voting power of the Company&#146;s then outstanding Voting Securities (other than, in each such case, with respect to matters concerning </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the rights of Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&#8195;<U>Reviewing Party</U>: means any appropriate person or body consisting of a member or members of the Company&#146;s Board of
Directors or any other person or body appointed by the Company&#146;s Board of Directors who is not a party to the particular Claim for which Indemnitee is seeking indemnification, or Independent Legal Counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&#8195;<U>Voting Securities</U>: means any securities of the Company that vote generally in the election of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.&#8194;&#8195;<U>Basic Indemnification Arrangement; Advancement of Expenses</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;In the event Indemnitee was, is or becomes a party to or witness or other participant in, or is threatened to be made a party to or
witness or other participant in, a Claim by reason of (or arising in part out of) an Indemnifiable Event, the Company shall indemnify Indemnitee to the fullest extent permitted by law, as soon as practicable but in any event no later than thirty
(30)&nbsp;days after written demand is presented to the Company, against any and all Indemnifiable Amounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;If so requested by
Indemnitee, the Company shall advance any and all Expenses incurred by Indemnitee (an &#147;<U>Expense Advance</U>&#148;) in connection with any Claim not initiated by Indemnitee. Such advance shall be made within ten (10)&nbsp;days after the
receipt by the Company of a statement or statements requesting such advances. The Company shall, in accordance with such request (but without duplication), either (i)&nbsp;pay such Expenses on behalf of Indemnitee, or (ii)&nbsp;reimburse Indemnitee
for such Expenses. Indemnitee&#146;s right to an Expense Advance is absolute, payable in advance of any disposition of a Claim, and shall not be subject to any prior determination by the Reviewing Party that the Indemnitee has satisfied any
applicable standard of conduct for indemnification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;For the avoidance of doubt, the obligations of the Company provided for in
this Section&nbsp;3 shall apply to Claims arising out of alleged breach of fiduciary duty, negligence, or the actions or omissions of Indemnitee if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not
opposed to the best interests of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;For purposes of this Agreement, the meaning of the phrase &#147;to the fullest
extent permitted by applicable law&#148; shall include, but not be limited to, the following: (i)&nbsp;to the fullest extent permitted by the provision of the PBCL that authorizes or contemplates additional indemnification by agreement, or the
corresponding provision of any amendment to or replacement of the PBCL; and (ii)&nbsp;to the fullest extent authorized or permitted by any amendments to or replacements of the PBCL adopted after the date of this Agreement that increase the extent to
which a corporation may indemnify its officers and directors. If a proceeding for which Indemnitee is entitled to be indemnified hereunder asserts a claim against (y)&nbsp;the lawful spouse or legally recognized domestic partner of Indemnitee or
(z)&nbsp;a property interest of such spouse or domestic partner, then indemnification shall be extended to such spouse or domestic partner or for the protection of the property of such spouse or domestic
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
partner to the extent that the proceeding does not arise from any actual or alleged act, error, or omission of such spouse or domestic partner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&#8195;Notwithstanding the foregoing, (i)&nbsp;the indemnification obligations of the Company under this Section&nbsp;3 shall be subject to
the condition that the Reviewing Party shall not have determined (in a written opinion, in any case in which the Independent Legal Counsel referred to in Section&nbsp;6(b) hereof is involved) that the Company would be prohibited under applicable law
from indemnifying Indemnitee to the fullest extent permissible, and (ii)&nbsp;the obligation of the Company to make an Expense Advance pursuant to this Section&nbsp;3 shall be subject to the condition that, if, when and to the extent that it shall
be ultimately determined that the Company would be prohibited under applicable law from indemnifying Indemnitee, the Company shall be entitled to be reimbursed by Indemnitee (who hereby agrees to reimburse the Company) for all such amounts
theretofore paid (it being understood and agreed that the foregoing agreement by Indemnitee shall be deemed to satisfy any requirement that Indemnitee provide the Company with an undertaking to repay any Expense Advance if it is ultimately
determined that the Indemnitee is not entitled to indemnification under applicable law); <U>provided</U>, <U>however</U>, that if Indemnitee has commenced or thereafter commences legal proceedings in a court of competent jurisdiction to secure a
determination that indemnification of the Indemnitee would not be prohibited under applicable law, any determination made by the Reviewing Party that Indemnitee would be prohibited from being indemnified under applicable law shall not be binding and
Indemnitee shall not be required to reimburse the Company for any Expense Advance until a final judicial determination is made with respect thereto (as to which all rights of appeal therefrom have been exhausted or lapsed). Indemnitee&#146;s
undertaking to repay such Expense Advances shall be unsecured and interest-free. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&#8195;&#8195;&#8194;&#8195;&#8195;<U>Indemnification
for Additional Expenses</U>. The Company shall indemnify Indemnitee against any and all Expenses and, if requested by Indemnitee, shall advance such Expenses to Indemnitee subject to and in accordance with Section&nbsp;3(b), which are incurred by
Indemnitee in connection with any action brought by Indemnitee for (a)&nbsp;indemnification or an Expense Advance by the Company under this Agreement or any Charter or Bylaw provision now or hereafter in effect and/or (b)&nbsp;recovery under any
directors&#146; and officers&#146; liability insurance policies maintained by the Company, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, Expense Advance, or insurance recovery, as the case may be.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&#8195;&#8195;&#8194;&#8195;&#8195;<U>Partial Indemnity, Etc</U>. If Indemnitee is entitled under any provision of this Agreement to
indemnification by the Company for some or a portion of the Expenses or other Indemnifiable Amounts in respect of a Claim but not, however, for all of the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion
thereof to which Indemnitee is entitled. Moreover, notwithstanding any other provision of this Agreement, to the extent that Indemnitee has been successful on the merits or otherwise in defense of any or all Claims relating in whole or in part to an
Indemnifiable Event or in defense of any issue or matter therein, including dismissal without prejudice, Indemnitee shall be indemnified against all Expenses incurred in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&#8195;&#8194;&#8195;&#8195;&#8195;<U>Indemnification Procedure and Determination</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request for the Company to
indemnify and hold harmless Indemnitee, including therein or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to
indemnification following the final disposition of such Claim, in accordance with this Agreement. The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has
requested indemnification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;Upon written request by Indemnitee for indemnification, a determination, if required by applicable
law, with respect to whether Indemnitee is permitted under applicable law to be indemnified, shall be made in accordance with Section&nbsp;7, in the specific case as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&#8195;If there has not been a Change in Control during the term of this Agreement, the Reviewing Party shall be selected by (a)&nbsp;a
majority vote of the Disinterested Directors, even though less than a quorum of the Board, or (b)&nbsp;if there are no Disinterested Directors, by a majority vote of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;If there has been a Change in Control of the Company during the term of this Agreement, then with respect to all matters
thereafter arising concerning the rights of Indemnitee to indemnity payments and Expense Advances under this Agreement or any Charter or Bylaw provision now or hereafter in effect, the Company shall seek legal advice only from Independent Legal
Counsel selected by Indemnitee. Such counsel, among other things, shall render its written opinion to the Company and Indemnitee as to whether and to what extent the Indemnitee would be permitted to be indemnified under applicable law. The Company
agrees to pay the reasonable fees of the Independent Legal Counsel and to indemnify fully such counsel against any and all expenses (including attorneys&#146; fees), claims, liabilities, and damages arising out of or relating to this Agreement or
its engagement pursuant hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Indemnitee shall cooperate with the Reviewing Party making such determination with respect to
Indemnitee&#146;s entitlement to indemnification, including providing to Reviewing Party upon reasonable advance request any documentation or information that is not privileged or otherwise protected from disclosure and that is reasonably available
to Indemnitee and is reasonably necessary to such determination. Any costs or expenses (including attorneys&#146; fees and disbursements) incurred by Indemnitee in so cooperating with the Reviewing Party shall be borne by the Company (irrespective
of the determination as to Indemnitee&#146;s entitlement to indemnification), and the Company shall indemnify and hold harmless Indemnitee therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&#8195;&#8194;&#8195;&#8195;&#8195;<U>Presumptions and Burdens of Proof</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;In connection with any determination by the Reviewing Party or otherwise as to whether Indemnitee is entitled to be indemnified
hereunder the Reviewing Party or court </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall presume that the Indemnitee has satisfied the applicable standard of conduct and is entitled to indemnification, and the burden of proof shall be on the Company to establish, by clear and
convincing evidence, that Indemnitee is not so entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;Neither the failure of the Company (including its Board of Directors
or Independent Legal Counsel) to have made a determination prior to the commencement of such action that indemnification or advancement of Expenses is proper in the circumstances because the Indemnitee has met the applicable standard of conduct or
had any particular belief, nor an actual determination by the Company (including its Board of Directors or Independent Legal Counsel) that indemnification is improper because the Indemnitee has not met such applicable standard of conduct or did not
have such belief, shall be a defense to the action or create a presumption that the Indemnitee is not entitled to indemnification under this Agreement or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;For purposes of this Agreement, Indemnitee shall be deemed to have acted in good faith and in a manner he or she reasonably believed
to be in or not opposed to the best interests of the Company if Indemnitee&#146;s actions or omissions to act are taken in good faith reliance upon the records of the Company, including its financial statements, or upon information, opinions,
reports, or statements furnished to Indemnitee by the officers or employees of the Company in the course of their duties, or by committees of the Company&#146;s Board of Directors, or by any other person (including legal counsel, accountants, and
financial advisors) as to matters Indemnitee reasonably believes are within such other person&#146;s professional or expert competence. In addition, the knowledge and/or actions, or failures to act, of any director, officer, agent, or employee of
the Company shall not be imputed to Indemnitee for purposes of determining the right to indemnity hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;For purposes of
this Agreement, the termination of any Claim, by judgment, order, settlement (whether with or without court approval), or conviction, or upon a plea of <I>nolo contendere</I>, or its equivalent, shall not create a presumption that Indemnitee did not
meet any particular standard of conduct or have any particular belief or that a court has determined that indemnification is not permitted by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&#8195;&#8195;&#8194;&#8195;&#8195;<U>Exclusions</U>. Notwithstanding any provision of this Agreement, the Company shall not be obligated
under this Agreement to make any indemnity or advancement of Expenses in connection with any Claim made against Indemnitee: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;for
which a final decision by a court or arbitration body having jurisdiction in the matter shall determine that such indemnification is not lawful; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other provision, except with
respect to any excess beyond the amount paid under any insurance policy or other indemnity provision; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;for the disgorgement of
profits made from the purchase or sale by Indemnitee of securities of the Company in violation of Section&nbsp;16(b) of the Exchange Act, or similar provisions of state statutory law or common law, with respect to transactions not approved or
authorized by the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;in connection with any Claim (or part of any Claim) initiated by the Indemnitee,
or any Claim by the Indemnitee against the Company or its directors, officers, employees, or other persons entitled to be indemnified by the Company, unless (i)&nbsp;the Company is expressly required by law to make the indemnification, (ii)&nbsp;the
Company has joined in the Claim, (iii)&nbsp;the Claim was authorized or consented to by the Board of Directors of the Company, or (iv)&nbsp;the Claim is one to enforce Indemnitee&#146;s rights under this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&#8195;for any Expenses incurred by the Indemnitee with respect to any Claim instituted by Indemnitee to enforce or interpret this
Agreement, if a court of competent jurisdiction determines that the material assertions made by the Indemnitee in such Claim were not made in good faith or were frivolous; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&#8195;for amounts, including any related Expenses, that are an excise tax or other penalty under Internal Revenue Code Sections 280G or
4999; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&#8195;to indemnify Indemnitee if a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> decision by a court having
jurisdiction in the matter shall determine that such indemnification is not lawful; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&#8195;to indemnify Indemnitee for the payment of
amounts required to be reimbursed to the Company pursuant to Section&nbsp;304 of the Sarbanes-Oxley Act of 2002, as amended, or any similar successor statute; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&#8195;to indemnify Indemnitee for the payment of amounts required to be reimbursed to the Company pursuant to Section&nbsp;954 of the
Dodd-Frank Wall Street Reform and Consumer Protection Act, as amended, or any similar successor statute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&#8195;&#8195;&#8194;&#8195;&#8195;<U>Contribution</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;To the fullest extent permissible by applicable law, if the indemnification provided for in this Agreement is unavailable to
Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for
Expenses, in connection with any claim relating to an Indemnifiable Event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Claim in order to reflect (i)&nbsp;the relative benefits
received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving rise to such Claim; and/or (ii)&nbsp;the relative fault of the Company (and its directors, officers, employees, and agents) and Indemnitee in connection
with such event(s) and/or transaction(s). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;The relative fault of the Company and any and all other parties (including officers
and directors of the Company other than Indemnitee) and Indemnitee shall be determined (i)&nbsp;by reference to the relative fault of Indemnitee as determined by the court or other governmental agency assessing the contribution amounts or
(ii)&nbsp;to the extent such court or other governmental agency does not apportion relative fault, by the Independent Legal Counsel (or such other party which makes a determination) after giving effect to, among other things, the relative intent,
knowledge, access to information, and opportunity to prevent or correct the subject matter of the Claims and other relevant equitable considerations of each party. The Company and Indemnitee agree that it would not be just and equitable if
contribution pursuant to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 8 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
this Section&nbsp;9 were determined by pro rata allocation or any other method of allocation that does not take account of the equitable considerations referred to in this Section&nbsp;9. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&#8195;&#8195;&#8195;&#8195;<U>Remedies of Indemnitee</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;In the event that (i)&nbsp;the Reviewing Party determines pursuant to Section&nbsp;6 of this Agreement that Indemnitee is not
entitled to indemnification, in whole or in part, under this Agreement, (ii)&nbsp;advancement of Expenses is not timely made pursuant to Section&nbsp;3 of this Agreement, (iii)&nbsp;no determination of entitlement to indemnification shall have been
made by the Reviewing Party within thirty (30)&nbsp;days after written demand is presented to the Company, (iv)&nbsp;payment of indemnification is not made within ten (10)&nbsp;days after a determination has been made that Indemnitee is entitled to
indemnification, or (v)&nbsp;a contribution payment is not made in a timely manner pursuant to Section&nbsp;9 of this Agreement, then Indemnitee shall have the right to commence litigation in any court in the Commonwealth of Pennsylvania having
subject matter jurisdiction thereof, and in which venue is proper, seeking an initial determination by the court or challenging any such determination by the Reviewing Party or any aspect thereof, including the legal or factual bases therefor, and
the Company hereby consents to service of process and to appear in any such proceeding. Alternatively, Indemnitee, at Indemnitee&#146;s option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial
Arbitration Rules of the American Arbitration Association. Indemnitee shall commence such proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the right to commence such
proceeding or such right shall expire. The Company shall not oppose Indemnitee&#146;s right to seek any such adjudication or award in arbitration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;If a determination shall have been made by the Reviewing Party that Indemnitee is not entitled to indemnification, any judicial
proceeding or arbitration commenced pursuant to this Section&nbsp;10 shall be conducted in all respects as a <I>de novo</I> trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination. In any
judicial proceeding or arbitration commenced pursuant to this Section&nbsp;10, the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;If a determination shall have been made by the Reviewing Party that Indemnitee is entitled to indemnification, the Company shall be
bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;10, absent a prohibition of such indemnification under applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;10
that the procedures and presumptions of this Agreement are not valid, binding, or enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&#8195;&#8195;&#8195;&#8195;<U>Defense of Claims</U>. The Company shall be entitled to participate in the defense of any Claim relating to
an Indemnifiable Event or to assume the defense thereof (with reasonable participation by the Indemnitee), with counsel reasonably satisfactory to the Indemnitee; provided that if Indemnitee believes, after consultation with counsel selected by
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indemnitee, that (a)&nbsp;the use of counsel chosen by the Company to represent Indemnitee would present such counsel with an actual or potential conflict of interest, (b)&nbsp;the named parties
in any such Claim (including any impleaded parties) include both the Company and Indemnitee and Indemnitee concludes that there may be one or more legal defenses available to him or her that are different from or in addition to those available to
the Company, (c)&nbsp;any such representation by such counsel would be precluded under the applicable standards of professional conduct then prevailing, or (d)&nbsp;Indemnitee concludes that such counsel has failed, or is failing, to adequately
protect the interests of the Indemnitee after written notice to such counsel and the Company explaining in reasonable detail the basis for such conclusion, then Indemnitee shall be entitled to retain separate counsel (but not more than one law firm
plus, if applicable, local counsel in respect of any particular Claim) at the Company&#146;s expense. The Company shall not be liable to Indemnitee under this Agreement for any amounts paid in settlement of any Claim relating to an Indemnifiable
Event effected without the Company&#146;s prior written consent. The Company shall not, without the prior written consent of the Indemnitee, effect any settlement of any Claim relating to an Indemnifiable Event that the Indemnitee is or could have
been a party to, unless such settlement solely involves the payment of money and includes a complete and unconditional release of Indemnitee from all liability on all claims that are the subject matter of such Claim. Neither the Company nor
Indemnitee shall unreasonably withhold its or his or her consent to any proposed settlement; provided that Indemnitee may withhold consent to any settlement that does not provide a complete and unconditional release of Indemnitee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&#8195;&#8195;&#8195;&#8195;<U>Nonexclusivity, Etc</U>. The rights of the Indemnitee hereunder shall be in addition to any other rights
Indemnitee may have under the Company&#146;s Charter or Bylaws or the PBCL or otherwise. To the extent that a change in applicable law (whether by statute or judicial decision) permits greater indemnification by agreement than would be afforded
currently under the Company&#146;s Charter or Bylaws or this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&#8195;&#8195;&#8195;&#8195;<U>Liability Insurance</U>. To the extent the Company maintains an insurance policy or policies providing
directors&#146; and officers&#146; liability insurance (&#147;<U>D&amp;O Insurance</U>&#148;), Indemnitee shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available for any
Company director or officer. If, at the time of the receipt of notice of a Claim pursuant to the terms hereof, the Company has D&amp;O Insurance in effect, the Company shall give prompt notice of the Claim to the insurers in accordance with the
procedures set forth in the respective policies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&#8195;&#8195;&#8195;&#8195;<U>Period of Limitations</U>. No legal action shall be
brought and no cause of action shall be asserted by or in the right of the Company against Indemnitee, Indemnitee&#146;s spouse or legally recognized domestic partner, heirs, executors, or personal or legal representatives after the expiration of
two (2)&nbsp;years from the date such cause of action shall arise, and any claim or cause of action of the Company shall be extinguished and deemed released unless asserted by the timely filing of a legal action within such period; <U>provided</U>,
<U>however</U>, that if any shorter period of limitations is otherwise applicable to any such cause of action such shorter period shall govern. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&#8195;&#8195;&#8195;&#8195;<U>Subrogation</U>. In the event of payment under this Agreement, the Company shall be subrogated to the extent
of such payment to all of the rights of recovery of Indemnitee, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 10 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
who shall execute all papers reasonably required and shall do everything that may be reasonably necessary to secure such rights, including the execution of such documents necessary to enable the
Company effectively to bring suit to enforce such rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&#8195;&#8195;&#8195;&#8195;<U>Modification and Waiver</U>. No supplement,
modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof
(whether or not similar), nor shall such waiver constitute a continuing waiver. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&#8195;&#8195;&#8195;&#8195;<U>Notice by
Indemnitee</U>. Indemnitee agrees to promptly notify the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information, or other document relating to any Claim or matter which may be subject to
indemnification or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligations which it may have to the Indemnitee under this Agreement or otherwise, except to the
extent that such failure or delay materially prejudices the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&#8195;&#8195;&#8195;&#8195;<U>Notices</U>. All notices,
requests, demands, and other communications under this Agreement shall be in writing and shall be deemed to have been duly given if (a)&nbsp;delivered by hand and receipted for by the party to whom said notice or other communication shall have been
directed, (b)&nbsp;mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed, (c)&nbsp;mailed by reputable overnight courier and receipted for by the party to whom said notice or
other communication shall have been directed, or (d)&nbsp;sent by facsimile or electronic transmission, with receipt of confirmation that such transmission has been received: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If to Indemnitee, to the address indicated on the signature page of this Agreement, or such other address as
Indemnitee shall provide to the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If to the Company, to </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Coherent Corp. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:
Chief Executive Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">375 Saxonburg Blvd. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Saxonburg, PA 16056 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">or to any
other address as may have been furnished to Indemnitee by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.&#8195;&#8195;&#8195;&#8195;<U>Successors and Assigns</U>. This
Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors, (including any direct or indirect successor by purchase, merger, consolidation, or otherwise to all or
substantially all of the business and/or assets of the Company), assigns, spouses or legally recognized domestic partners, heirs, executors, and personal and legal representatives. The Company shall require and cause any successor (whether direct or
indirect by purchase, merger, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 11 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consolidation, or otherwise) to all or substantially all of the business and/or assets of the Company, by written agreement in form and substance satisfactory to Indemnitee and his or her
counsel, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.&#8195;&#8195;&#8195;&#8195;<U>Duration of Agreement</U>. All agreements and obligations of the Company contained herein shall continue
during the period Indemnitee is an officer, director, employee, trustee, or agent of the Company or of any other entity or enterprise at the Company&#146;s request and shall continue thereafter so long as Indemnitee shall be subject to any Claim by
reasons of his or her Corporate Status, whether or not he or she is acting or serving in any such capacity at the time any liability or expense is incurred for which indemnification can be provided under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.&#8195;&#8195;&#8195;&#8195;<U>Severability</U>. The provisions of this Agreement shall be severable in the event that any of the
provisions hereof (including any provision within a single section, paragraph or sentence) are held by a court of competent jurisdiction to be invalid, void, or otherwise unenforceable in any respect, and the validity and enforceability of any such
provision in every other respect and of the remaining provisions hereof shall not be in any way impaired and shall remain enforceable to the fullest extent permitted by law. In the event any provision hereof conflicts with any applicable law, such
provision shall be deemed modified, consistent with the aforementioned intent, to the extent necessary to resolve such conflict. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22.&#8195;&#8195;&#8195;&#8195;<U>Enforcement</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby to
induce Indemnitee to serve or continue to serve as an officer and/or director and/or agent of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as an officer and/or director and/or agent of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof
and supersedes all prior agreements and understandings, oral, written, and implied, between the parties hereto with respect to the subject matter hereof; <U>provided</U>, <U>however</U>, that this Agreement is a supplement to and in furtherance of
the Charter, the Bylaws, and applicable law, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;The Company and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate,
impracticable, and difficult to prove, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree that Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific
performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining any other relief to which
Indemnitee may be entitled. The Company and Indemnitee further agree that Indemnitee shall be entitled to such specific performance and injunctive relief, including temporary restraining orders, preliminary
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 12 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
injunctions, and permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or
undertaking may be required of Indemnitee by a court, and the Company hereby waives any such requirement of such a bond or undertaking. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.&#8195;&#8195;&#8195;&#8195;<U>Counterparts</U>. This Agreement may be executed in counterparts, each of which shall for all purposes be
deemed to be an original but all of which together shall constitute one and the same agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24.&#8195;&#8195;&#8195;&#8195;<U>Headings</U>. The headings of the sections and paragraphs of this Agreement are inserted for
convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction or interpretation thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25.&#8195;&#8195;&#8195;&#8195;<U>Governing Law</U>. This Agreement shall be governed by and construed and enforced in accordance with the
laws of the Commonwealth of Pennsylvania applicable to contracts made and to be performed in such state without giving effect to the principles of conflicts of laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 13 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">COHERENT CORP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">James R. Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Sherri R. Luther</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Address: {redacted}</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 14 - </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d888602dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g888602g1010074607600.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:10.00em; font-size:10pt; font-family:Times New Roman">Coherent Corp.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:10.00em; font-size:10pt; font-family:Times New Roman">375 Saxonburg Blvd.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; text-indent:10.00em; font-size:10pt; font-family:Times New Roman">Saxonburg, PA 16056-9499</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PRESS RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COHERENT APPOINTS SHERRI LUTHER AS CHIEF FINANCIAL OFFICER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PITTSBURGH, October&nbsp;11, 2024 (GLOBE NEWSWIRE) &#150; Coherent Corp. (the &#147;Company&#148; or &#147;Coherent&#148;) (NYSE: COHR), a global leader in
materials, networking, and lasers, today announced that following a comprehensive search, it has appointed Sherri Luther as the Company&#146;s new Chief Financial Officer and Treasurer, effective today. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Luther joins Coherent from Lattice Semiconductor (&#147;Lattice&#148;), where she was Chief Financial Officer since 2019. Before Lattice,
Ms.&nbsp;Luther spent 16 years at Coherent Inc., prior to its acquisition, including as Corporate Vice President of Finance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are pleased to
welcome Sherri Luther back to Coherent&#146;s leadership team,&#148; said Jim Anderson, Chief Executive Officer. &#147;Our time working together at Lattice and her previous tenure at Coherent, combined with her proven track record as a public
company CFO, make Sherri an ideal leader to help us unlock the full potential of Coherent.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am excited to join Coherent as its next
CFO,&#148; said Ms.&nbsp;Luther. &#147;Coherent is well positioned to build on its momentum and deliver enhanced profit growth and cash generation over the long term.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I would like to thank Rich Martucci for his outstanding leadership as Interim CFO and for his continued service at Coherent,&#148; said
Mr.&nbsp;Anderson. &#147;His experience and leadership will ensure a smooth transition, and I am grateful for his commitment and continued dedication to the company.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>About Sherri Luther </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Luther has more than 30
years of strategic and financial operations experience, with an expertise in financial reporting, forecasting, internal audit, M&amp;A, treasury, investor relations, operations and global supply chain management. Prior to joining Lattice in 2019,
Ms.&nbsp;Luther worked at Coherent Inc. for 16 years, including as Corporate Vice President of Finance. Previously Ms.&nbsp;Luther had senior finance and accounting roles at companies including Quantum, Ultra Network Technologies and Arthur
Andersen. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Luther is a Certified Public Accountant (CPA) and graduated from the Executive MBA Program at Stanford University Graduate School of
Business. She holds a Bachelor of Business Administration, with a dual major in Accounting and Finance, from Wright State University. She serves on the Board of Directors of Silicon Labs and is also NACD (National Association of Corporate Directors)
Directorship Certified. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">coherent.com&#8195; | &#8195; T. 724 352 4455</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>About Coherent </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent empowers market innovators to define the future through breakthrough technologies, from materials to systems. We deliver innovations that resonate
with our customers in diversified applications for the industrial, communications, electronics, and instrumentation markets. Coherent has research and development, manufacturing, sales, service, and distribution facilities worldwide. For more
information, please visit us at coherent.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amy Wilson </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Manager, Corporate Communications&nbsp;&amp; Investor
Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">corporate.communications@coherent.com </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward
Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The statements contained in this press release include forward-looking statements relating to future events and expectations,
including statements regarding the Company&#146;s ability to benefit from the noted executives&#146; experience and expertise which is based on certain assumptions and contingencies. The forward-looking statements are made pursuant to the safe
harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and relate to the Company&#146;s performance on a going-forward basis. The forward-looking statements contained herein involve risks and uncertainties, which could cause
actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company believes that all forward-looking statements made by it herein have a reasonable basis, but there can be no assurance that management&#146;s expectations, beliefs, or projections as expressed in the forward-looking statements will actually
occur or prove to be correct. In addition to general industry and global economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements herein include but are not limited to:
(i)&nbsp;the failure of any one or more of the assumptions stated herein to prove to be correct; (ii)&nbsp;the risks relating to forward-looking statements and other &#147;Risk Factors&#148; discussed in the Company&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2023, and additional risk factors that may be identified from time to time in filings of the Company; (iii)&nbsp;the substantial indebtedness the Company incurred in
connection with its acquisition (the &#147;Transaction&#148;) of Coherent, Inc. (&#147;Coherent&#148;), the need to generate sufficient cash flows to service and repay such debt, and the Company&#146;s ability to generate sufficient funds to meet
its anticipated debt reduction goals; (iv)&nbsp;the possibility that the Company may not be able to continue its integration progress and/or take other restructuring actions, or otherwise be able to achieve expected synergies, operating efficiencies
including greater scale, focus, resiliency, and lower operating costs, and other benefits within the expected time frames or at all and ultimately to successfully fully integrate the operations of Coherent with those of the Company; (v)&nbsp;the
possibility that such integration and/or the restructuring actions may be more difficult, time-consuming, or costly than expected or that operating costs and business disruption (including, without limitation, disruptions in relationships with
employees, customers, or suppliers) may be greater than expected in connection with the Transaction and/or the restructuring actions; (vi)&nbsp;any unexpected costs, charges, or expenses resulting from the Transaction and/or the restructuring
actions; (vii)&nbsp;the risk that disruption from the Transaction and/or the restructuring actions materially and adversely affects the respective businesses and operations of the Company and Coherent; (viii)&nbsp;potential adverse reactions or
changes to business relationships resulting from the completion of the Transaction and/or the restructuring actions; (ix)&nbsp;the ability of the Company to retain and hire key employees; (x)&nbsp;the purchasing patterns of customers and end users;
(xi)&nbsp;the timely release of new products and acceptance of such new products by the market; (xii)&nbsp;the introduction of new </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
products by competitors and other competitive responses; (xiii)&nbsp;the Company&#146;s ability to assimilate other recently acquired businesses, and realize synergies, cost savings, and
opportunities for growth in connection therewith, together with the risks, costs, and uncertainties associated with such acquisitions; (xiv)&nbsp;the Company&#146;s ability to devise and execute strategies to respond to market conditions;
(xv)&nbsp;the risks to realizing the benefits of investments in R&amp;D and commercialization of innovations; (xvi)&nbsp;the risks that the Company&#146;s stock price will not trade in line with industrial technology leaders; and/or (xvii)&nbsp;the
risks of business and economic disruption related to worldwide health epidemics or outbreaks that may arise. The Company disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new
information, future events or developments, or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cohr-20241010.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 10/11/2024 3:47:47 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:cohr="http://www.coherent.com/20241010"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.coherent.com/20241010"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cohr-20241010_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cohr-20241010_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cohr-20241010_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 10/11/2024 3:47:47 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cohr-20241010_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 10/11/2024 3:47:47 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cohr-20241010.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g888602g1010074607600.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888602g1010074607600.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J -D# 2(  A$! Q$!_\0
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M;J0))"P'S>];OQ.U"'5OA=;ZA!_JKF2&50>V03CZBN9^!O\ R&]4_P"O9?\
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M4CB::K/XHWB_O7Z)'%B(N#Y>CLS[ M?^/2'_ *YK_*O!/C3_ ,CO%_UY1_\
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M!-A9VE]=-;6D$+-& 3'&%)&?:EAJULFJ4[;O_(=2/^U19ROQU_X]]#_WI_\
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<A(U"@?,>PK8KSL?+FQ51_P!Y_F;T5:G%>2/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g888602g1010080119139.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888602g1010080119139.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  L -H# 2(  A$! Q$!_\0
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M<=;S^,;R!9[6;7)X6Z/&\K*?Q!KIOC3_ ,CK!_UY)_Z$U>D_"C'_  KO3O\
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M6HQ<5JSIDG>?]GJ57.?*NA&OT\T'^M<!HFNZEX?NY+G2YS#,Z>6S!<Y7(/\
M05ZCJ^E/H_P!CMI5VS.8II >Q>0-_(BL'X,VT%UXKO$N(8Y5%D2%=01G>OK6
M.%Q%*&$Q-5QYH\\M.^PYPDZD(WL[(Y37/%>M>(H88=5NC-'$^] 5Q@XQ7IOP
M*_X\=;_Z[1?^@M2?&JQM+71M*:WMHH2URP)C0+GY/:E^!?\ QXZW_P!=HO\
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M?$EW?2R744LX5G6)U"YQC/*GTK+)<>J.*JQEM*[_ !_X)6*I<U.+['H'AO\
MY%?2?^O.'_T 5Y!\<?\ D8=*_P"O1O\ T.O9]*@6UTFSMD)*10)&I;K@*!S7
M%>/_  G8>(M2LY[N6Y1HH2BB)E (SGG(-<&45HT\P51[:FV)BW1MZ#?@W_R(
M:_\ 7W+_ $KT.N8\#Z-;:#X>%E:O*\8F=\RD$Y./0"NFKBS":GBZDEU;-:*M
$32/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g888602g1010084511512.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g888602g1010084511512.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  L -H# 2(  A$! Q$!_\0
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MC_<?]<(O_0:Q;'QEXIT^QBM++4[F*VB7;&B@8 _*MKXO_P#(_P!Q_P!<(O\
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M]+AE229-CEY2V1G/>LL/CZ<,KGAFGS-_+IYE3HR>(4^AP/QU_P"/?0_]Z?\
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'+C!)]C__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45688585167792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000820318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 10,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Coherent Corp.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">25-1214948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">375 Saxonburg Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Saxonburg<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">16056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(724)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">352-4455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">COHR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " !904M9)!Z;HJT
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M2P$"% ,4    " !904M9!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( %E!2UG95MJV[@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M %E!2UF97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ 64%+67]*)T\Y!   ?A   !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M %E!2UF?H!OPL0(  .(,   -              "  7P,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ 64%+69>*NQS     $P(   L              ( !
M6 \  %]R96QS+RYR96QS4$L! A0#%     @ 64%+61PX9>H_ 0  / (   \
M             ( !01   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( %E!
M2UDD'INBK0   /@!   :              "  :T1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( %E!2UEED'F2&0$  ,\#   3
M          "  9(2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(  -P3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d888602d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cohr-20241010.xsd</File>
    <File>cohr-20241010_lab.xml</File>
    <File>cohr-20241010_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d888602d8k.htm">d888602d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d888602d8k.htm": {
   "nsprefix": "cohr",
   "nsuri": "http://www.coherent.com/20241010",
   "dts": {
    "schema": {
     "local": [
      "cohr-20241010.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cohr-20241010_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cohr-20241010_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d888602d8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-10-10_to_2024-10-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d888602d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-10-10_to_2024-10-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d888602d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.coherent.com//20241010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001193125-24-236461-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-236461-xbrl.zip
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M]]!KT;$' (3V$V6EC8.F"\]U'J9C1SK]M[BK0NROXG08C]*$C$6@'F6]I83
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M12'(*D%>"NDSOA9M&#[DL_52WG&IMO3OG<AWT>RW+Z@]_P%02P,$%     @
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M9D!7D"YWM/ >*186[\5>ED(BWLA2?^38H#J>^U+.^>SI=2E*5PDH(;)_7"W
MGB&I'=OR$% 0@4_4!ZV Z)M;X&&9 0J69#E=T1^QA&X9L85"^R_4"2B(%NBB
MXSI6-D)O\ '^!'Y$$NM.59*!EMP#:!3 =+!##%F$4T+]2 *J>,:@+CT6?H?7
MR8!/!^$*P7._7E7RYYS+8BRT.UB:$ZT>ST.&BV'D?W&E-X)Y\GH97+Z2 %8
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M)@/GJ*1(7V^J@PXZ=T\2US"#@R<87F6R2EAPVAAS<P'?(2BTS_X?4$L#!!0
M   ( %E!2UDT 0I<*[D  -NR P 1    9#@X.#8P,F1E>#$P,2YH=&WLO6E3
M&UFV-OI=$?H/&>[N$Q"18, &C^VX,I:K.->%?0!7==TWW@\I94K*<BI3E0-8
MY]??->TI!P'&(%S%B3A=1DKMW,/::U[/>OWSV2\?WKS^>3AX]Z;?>WUV=/9A
M^&;XGZW=G>W=UX_Y3_C\L3S@O7[[\=WOWMN?#C]^^'CR[T>__7QT-GSDG9[]
M_F'X[T=)G$9;LRB>SLJ7QUD^#Y)';[Q^#WY_&*5EE+]Y_>[H5_7P11R6LY?/
MM_?C])$7)/$TA0&B2?F(7O-)/38/\FF<;I79XN7.HGSER=^CK"RS.7\TR=)R
MJXC_-WJY:_Z>!/,X6;X\B^=1X1U'%]Y)-@_@38,/1S\=__M1CI-\].;UVS?#
MK[-X%)<>KMA[_?CMF]>//[VQ)F"-O@>CU^;3F,ZC-_^5CHK%*QR%EGXV>/MA
MZ!T./WPX_30X/#K^Z=^/=A[1WY\&[]ZIOW\[>G?V\[\?[>[L_.N1]_;CR;OA
M"7TND^!/MF#7/PP^G0Y?JG^L7&Q]9_3BQW0:CVA^'D[QY(W\XYV:R/[NOV!W
M'I^],]_\*K_FM9HIJP?= 9X^5Y_#_YQ8KU)+6@33:&N41\&7K3@MXC!Z&9QG
M<>A=;TEO:I.#<^%UP<='O_SDG9X<_OO1]/GSYP<[>]/='=C?YSN[NR]VG[S8
M_F,QQ1TY^_>C#Q]_^OC(I<N][2<[3W>?Q>DKH>>=[:<'\'_XR2.Z$6;%M8T1
M E!DT'R.YG@]$B^CKR5L4P@']W+W8'MG)YI?C^[?'&:S*(>?>X=9OMAFZKSC
M*3QYMN^=!E^S=%3E4^]M<AZN9QYZ#K[W:7"]&>Q^GQGL'NSL'VR]>/KBA??Y
ME*9@WQ3X#_*,#A(A+G13-OCFX[C,1E'.1/K<]_9V]IYZ-<[WW5]Z"B28Q_W>
MAZJ$?]WZZ]Y%0>[Q.U_>^LL^IMXHF@7)Q,LFGGO9O U8;K_W7__8??KLU6$V
M7P3ITL>_GK_R^,.+2/[,<OFD*OB33=\+TM KJM$?T;CTRLR#L;Q@L<BS\R#!
M=^'?.&B4%D$99RD]_W,%D_(.@T5<PE/P]3PNRRBRG\=)>$=>,/<6210448B#
MC[-T$N=S[R(N9]XRJ^AID!7S G^:53G\9Q+A_WK1?)%DRSFL<MM;<8F^S^[N
M;O_7/Y[OOMA_]?KSF],RR$OO75!&<'^S(M:+?E>5<52\?OSYS;;W.\ZUH"=#
M>!(6E"1P0)Y#][N[3/@^[GM1C6=>1H1)OP@*[R*"B2^]>55609(LO6":PQ[B
M:<HIT53Z/9R+'!>]F=]61/DY#6/M.#YU\*KP#F=Q-/'>QVF0CF,XH8^323Q6
MT_JO8+YXY9V!:"RJ/,I]+X\665[&Z12/: [+IN,):;FT\@ N5);'Y1(/L(B+
M$FF/'J)5+627[N"@].IAKZ.O"Z!9)JQ%E$] (T2:RM7,%WD,KX-AO$F>S8FZ
M3H.T#+S#),@#'\@WB>%':1P@U<'^^/8]P.W)TF"41-ZH*D#S+&"G\^ \2AJ;
M@"_M]]1^R8%<XP20W -OFF0C(H,,%A/0<2RJ41*/X7UTN-NWS]&J'%]+FVCN
MGT\W%7?]I;<1;_(2PN@\*X'KP([!-4C+F"D83H9^?9'E7XB@X!5,0B7N%UXE
MX3%Z4^G;R22(\Z+&/[R-Z.LXJ4(<"/\\#\;$@N"<XO$7#]@*7 "X6GRKF&D!
M.?#G\)J+63QF-A/D0"[P^C*)PDTD>)"N<B7Q&L')%'I>45'B/&@9P2A.@.R9
M259%)$=MTP8^'DV CDH: N8PAXVAH6)4@^'[^KI\V$:UCVD&/T^GH*S"X[1*
M7HV]_4AO54(4H5=KMF]<QN=X-<M9 /2854GHC6&"R&*(WP(%T8+4; S--M9N
MS\^>8% @O?=[.#T@3E@[3H0V=(G31@*-:'XTMGV$\!P\L  6$^3"8?CIJ/DL
M;O)&?"XOQL> I.I/*1:WR&!ABD'E51(5OMR])7'5$6THG S>9V( 1(NX4OCO
M';"J/4NFO'[_\?A,6P"SN(RVBD4PCEZFV44>@+I^Z0-#30];0;GU&US&UX_Q
M-V_T?[18,J33W&+%._E]_=Z*-\)K\.EM>8%W-HL+D Y!6GA13#1(-RL-'\,9
MM[UC@M(,]QOD._!!NA0PA#6]/$KH0A>S> $<@L@?3T<D$(R+_\VJTAL'</ON
MX-">6(?V_O>]?:*NHS2LQA'->/AGA30_N CRT*@"O.0\&D?Q.5_]298DV04Q
M+GK40\8'GQOEHKD8,]&#:SH"/.T'^+[VO.4HJ#L4Z@X'V\'P1BSQHEP"A_RW
MUV6+/ZK9]$_^91;5,/CW__7(L7"5LX%].L&V_1/[JTZSV'-WV+LI\;SR:G,:
M$N]!BF@</@L]Y%W I#1QP5UAJ3,>1PL0JF-1J.."U6(CB#6M142/P)F9RF)^
M49FA6A[,LRHEUO_/W6?^TYT=?P?^'_]FP?C/)_X^?X@:((@&F ,K+Z#Z5W5E
M7O%=OA7\.ES%/W>?^"^:PUS*T(IXFFYEJ>(NUC;(X!NDA(VS:0K;+PM5WZE]
MZ/= \$Z '3&'I]T;5SG91LQGHAQTYK,9S*HVA.)2893 1N81G0=?VX+-.6,S
M*XL9;>=W1[_"W^)P)*<3$MV"B=WE2&BWUV@*/[)NPRB"^<-M2"Z"98'4^7B!
M+_GYQ#L]^O]@XYX\4N.20_3E/U[0_]7\>4)UA\/CL^')M[I$_QHL9'=W%0]Y
MNI*'Q/>0AYR<?BZV.ZBQU8G\-Q4=N_O?+CL&]_#<_[FK&+9BP\S3;>[+7'I#
M,UW4-I[N_$O]H/'H9BO/Z_=0X]HZ!\L !T +(8_)K"[*#*RL*HW+PG9*($F*
M-X+5M$M9?99&6R#%\E Q>_4RD8L3,/U0^4MQ4D60+]42;%?,C=]2@"Q!J6M>
MT^^UO =E&D\JA?V^\5OIN]5K>[C?MWN_W][#^PT:B??/?7__H.6.-U6A2VYZ
MQP_T?>_W'"7GIO=]']Y\_1M,%ZOEI\UK>?4;\F ]?:<K<GA/KTA:S4?L'T4J
MM.07^Q2 :$<46A!:NI1;/]G9"H.E8M5E'L0)D"*83T!ZZ((3RH.5?(E*=""/
MN\R@<3:?PUOYSL3S>13&0*C)$G^$_I"L3OX;.5AC(<RU6JAOT^AK";98!L=<
MS((\VO0MISJ[^3@V@E<';PEYV0M'P,.^J$L_S8-4W.$M$XZ^1N.*K5%V1:.U
MV.\-JFD%5Q?#% ]RZ);MB_MH8'QZ,##^G@;&GK_[+0;&P3<8&!*<(X=6AY+Q
MR2@9#]3X]U.'__G<?_+TFU7A:](DB/O">^![?U^M$I2R*:AW1KFT CR?KJ!G
MPGJ^3='T[HF>21[QSE5'08XKSLXQJ)YR7/UK/,?!KQ V?+*UA '4RFW6#_^.
ML]#;&$5PH*EE M:,Q"@-K2^3H, <&[(*X78_VS1'P>'#<\4L:&VP2@SMYU%9
MY:FWP=(E/SL]42:L(XQBH)D@[]"8B9?@3W%[A*E@##R\LI9.C]@LZ1M4=.]!
M0[^K(.+H'O*K88!49@LWH#)+++8$M6:8_J*\+"6F@M"3>)\D$H]I.$Z*G9?E
M_=YX%J2<A@)47.99,]&IA68Q^2>$=\L=F&!>2(.,_7J"8=>%T>E%+6\ZB<YC
MO/A#/?QIA.P4+_*G!!E56<)FL8]KD +3\P:.'VMX^DDQ 9Y&O_<)&$\\CA>\
M)0/,OV-E0PV%>9;P,(RH\OB/'+6U_??RFDW):+$7U?&+JWBXOGNRP]/K9*B<
M8KSVHX[7OLW2JBL!(KAV]'>$HZGH]33/"F2T)GR]KV+7BV!)65>8*@7<.YW"
MO\=!,<,OZ. V@DE)[!^N!9H?9?"52!?% CQ>;+H>RSR:5B@ X.= [PEG9IK<
MC;H7\G1&Z548?3[/$I@=IQ>")@K+X>BSRH54D@'N%%T*II>?,A" )Y0])AFY
M&T!:830A'2-.5U+E)J61\A3L?!O)(_G+1J9OK5@'!C>Y2;6D1SJT0\PZ:CDB
M#WF)9WT\BH!B-GW*../<**#*R-71KN+HMC(\0!$S5,QYA8N2B V(E4FXP@0(
MNBU6KL>5_*!MU^_VTTOW+7[32"E_&Z6PF:7PE-\DI1I3.D'4R[:P",*D#W5#
MQ_5A1C*,%[;FLC82]1_TI;]6TM7KHS=O\>J=!L#7P0 [:A-0:$%X!3V!:8=4
M\I"F%=@0.;("%#D'>_M-D3,>9WE("H>AQ9J64I<HBQP3=,>8G5K.P#2;SD!M
M6931W%0)4)' _K8W*#%UF>-H7!!@+"7'#MCWOZDJXVV&>IJEO>@G3'@O$:4/
M;:B+682LC+@:W:BX&(,V1 G89=;OQ2GF&1>4@AU&\F^Z;VH7K7WVC=DF5F^)
M6=B%SWG)&&M7+^:44-^QU-P"B@GL:9875O&#K!03?[71_A U_/N92W#]!WR3
MCU(L0\7;;M^3&D,@4RE0#B'A :10QOKG9%J1.D#V%\AD> 8D\O/]?U$""5&\
MS5$V8!+Q=K2-[_+UV#0**;-/=OV]_1W0%HR77-2*(IBC^IG/Z3IGUH=B,!6V
M2VKBYETK#B3U TU?@EH"7CE55D&*- C1D646BBU948T$,P[4SLV&HK75[VT0
M#]2;9_;E7[I\@C>$S:"?LB!!(PXK&9S!\FR:!W-O0RUG!#]*C3^,A]^4W';W
MI-H.";U/L%-D!M"!*6W*W;S1LLE#-1]YX!RWRSG&]Y-S?,C2Z=894(A%GBK3
MOU6/$#),\'=(676")).6Y!:'+3 8UDJ#(K[8M\._F,=?%1>@OS4'6"'Q_%:/
M3<CFZ379A5PX68=F?UA)E4>3A"OOA&_)0_"B<1Z/T ,SRLXCRB\XQ11XL':)
M4)X\.#!O]5Z%]_->&=/.N44C4Y-'%J[V>K"R3?>L!/N7B^!F49"@O$'W>Y1,
M@ Y]71#(%P4)N=\3 ]!;)%BI1'46>8Z.S3G5)4SAZYQK%<^#."'5'E[.MZ"(
MTMAV8#8*$MN- ,N=2?9JX?C_:2(/A'^KA!_=3\*W'-1Y5C(G;%X"JNV!.[!P
MW'Z6IXD?5XG)NEIRRO5U_1[3*Q>>=7FT.^K/'BCREBAR<C\I\@B4^GD:@XBO
M$4@W60K2 4=Y.G^OZ!6MEWYO5?SD"+T'7+]/9$MZT+*%P#-QJ3_0[!W1[/1^
MTNQ;5>H^_(JV6B1ZA'(1YU$\'U4Y^YY(4;7*\Y&F4M#6"_*W"WX#*05CRJP(
MF8S'65$6/G!2]$6509QR%%!I%:;:/I(IH*:/=89<Q6F] IDXBGYTELUH*Z8.
M* 5>"+*LG9BH<\?D'69A-!E5[[Z62.&!X[D_C](@+>O1/[C1M2BOJBU LV*L
M?@5*%@57RADY-5%:P3G]>J14+19XMU[H_<Q:T2]P5E$":EJ4J9CF0Y3@KQXE
M.,Y T# ZAC"4MTL/#64._,:%ET1@84O1M<XWK*7N,.H&HX(\U S_F+3]O)6V
MNPD5U)N. GV6+%HE0L6'GEP)R:']K(4R)(F=(NZ*AF_!'X&Y&V<)159R\O.
MZ5P1R@LND;.$<#PGJT=AX]ASHNK_?D_AX@0DLY:B?C$UTQ<X SL$G8U0,M+<
M\?41QYL-)HR/215S]$'EBRP7=[*:@0&+ >LYRJV]L;:O ?MU*XJ>!9OY0]/M
M7R]T<UJ-48^BT!Y0XZ! ?BS<^<RP9,ST3-#[7^61@6UBMP]1)*8!>*.8\TBK
M!="AG5BF8[;L;T65Q'UOP.^M96\I$X6TN5D4R\-)-,6XL9(/E)!:^*#$"7&+
M>+#AU.#)!?II"5P*/U0LP*R0?H>7D*#!^'[!:]*@Q#5S#JHP"0IMX(1)X:58
M+,Y)8M:<]DLH3/T>*:<*4H>RE2A!Y2)'7W*J;O6#E?5W#'X,4_2UUAT"9[8B
M9,*&)&\BMNA]U.@+4>GQ*D8\DE*8C.QA#9_)$,D>Z&T<Y:G*M!/KH2!;(1?G
M09Q2LCH2/8DD2H2*"[QB=&O(:L+,/M^Y@Y1 @*1-SE]ZF\BJ+S%GG9HW9X7U
M;KFW 9EZ,%R1+"V+A6?D<22%)S> ,<&.-"X1I1'(39YCTL:(@R%XT1C,+B15
MD[+TQ3,GKW-$*^:/\%[Q>Q!$;[X@(4ZO7+J*:D:.;5\PU]3+"&'.<K58H_K:
M<D,:?XAZ_BVC,\,4:'L<"=0A7_LCT>M4-*-&U$QB<%N"Q2)1=(\:7;K,4I(V
M+-'@[WYO'.?C:EZ0NHSI/O"K\ ]@(_ SUBOI<IR#;1'R+R,UH41C(OY1Y7$1
MQF-!?\2PBOP$E4KW5[0,(QX#1@ TR(K6HG)G ;6+RR!9XP"!=[TI2'6-)J@D
M*&,OM,\<N%S7>QSI+;\7M5Z *=T]X"A2UV@.:J2]3P]B_.\8<OH)92<)M@_!
M19?FC 1-SZ'_DG(.X#L0/Q+2;PMQ)L%%H07X(16E77!$%C[\%*5IL4S. \32
M5;<C!R4TIPL>DTPW2*0TEB;H!SK].P:B?@LH"YXI]#CS)D&<H&DCVI!RHY,4
M(O<$T)$P15<T%0V^C:PU&),.%X#.12]2WF7JRV&/18;6 RW^K0-,OYD"(:;'
M :G(2\X8 <IQJ@S"*A*D3CN)$&E2,]<TTL2+!4C*":9JF@K'K39B+CN+DK ^
MH&A1+.U1%0#.^4"BMTJBL_M)HJ<F>03^DO_P$I_NO!@T!7U<D%2G2G#!W%9@
MVDY*'OY:R_4CE8I_$H&Z6R$AAN2"VGWQ_(#@M8,Y#^E4$82Z@""CBG&P-L%*
MC9F58_R?4/5\Y:J+OE)^HHF9.DYA:M)#FO7<U-)-J! ]Y$I13#/&6T7I 7)'
MNM9$*_#-9<9TR2RET@KX-RR.?M[OV0*$3')<QKD* E.6-)Q,BN8#IEJ68DNO
M?"W;[(:/Y*8X2;OWI+Y)_ #!B@I=8BXWW<-E;1/[O>OLHG@;S9S3!#T6.CU5
M3=P$)S VSE12(  \?TU0O0(]+U602)<26D"$<2K_GUQK=VE',04=O2(JU55>
M/<M F< )8O;M),KS()'WLK='656IRH55'UYA5PS37P1Q:"7-6UQ;#XB:3HEK
M55XK/!)<^9339RS_;Z;B+&5.U3/Q1,=E5)T,*N]JB8MH'$]B^$10CR-37DJ+
M5L6+*]="S6"6GA)2M* LM\^[[J8VLA"3)UM/^/J$^Q!'_3&E[O7CJ-^;S3/*
M3["4XI@B_NJ!G0K73>I!B$Z_+S_B1?#K50(;V,_5O$K(OZ4ND\LF2* DU1Q(
MMYJKM^WN>.,@B3 )" %/U*39I1Y>N;;W8(O6;"&PQ%E(+CW<QS".5&GL-XV6
M%25(*O+G$[ 7(KHX9<ZJ$A_+_T3<^6+&\1=2JLSM2KB&.J),JHP]#U+'?!VN
MJUZMPF1N-$Z7(T7 =J7O"&SW0?=VAU*_R(&[*"AGV]Y[Y(15#AL0%53W=0DM
M.M9F@/0E00BX0B5,GI.ZE/AJLE:]0D+P4(EFK2,*+>N]+^"T4XR5L :#.@^L
MQ(>SSV'.B31E47_Y4B 22 :QWA2LI)+X(X^[W>\-[(0[GKHH2!17T0K."IFA
M%T;ZERU?.EQ/8BQI:^R2C==1*A\K6'-;$OOU\9@*=7 8R=3-NHLIL(4IUO6\
M/^L2R37 66"+&2.,7:'NUZ! 3,V^'CT"P1"CRL!IC-9,5%2G?9M]-9V@=GQX
M]I877 )-5WQ9O^>^C8U5\T[']>R\U^D@Q'MN[RHS>OU^E?"H@E%$&$"^R$$%
M0D,C0=E75IV[NV07OH,^HC@X>O.M];.%Q(=)K+O?,[V'G,M;FWO+,<!0N,E6
M^F,2 XV%.@<&-$ &UYE8>J;\G,&XE,D_#[Y$.%H]FLF4:C'8PH4[6''A+K/]
MC A3=UFS#KZKMDL"CB>) T4U^"VM"-@[MI S=@:([HAJN($?<ZA1]Y\R.4&*
M$FEMNFF37##)"G>E0IJEM)S8L(A+K(2'>.9MN4KN(YPMUG^CB^*:&0Q">\J[
M 13*(7W22M!; %:13I-! 9Y7K %)%-^J8*!'PPH+S+AKXO]&88M"8MVI!X_>
MK9+I'_>33#\2"_RDPQBF "<8?P'M.XG":602,@FI0.J.0\DB"S"191$WRA15
M:>\I@D;V>Q\O4E",L<7:3R"3(NRBS@6]!DGMH\((P(%Y9O]OM#0/%/7B'-UH
M- DN1C!A[Q.6)TBC1(UA1'7'ELH5VFM3*$MS4YGL#K:62H>CB:3B6@$FRI+%
M+"95+4K:-+>UY35BU@,<Q;(>B^)S(BC*F--V[J*)W2F6H><1JO:W#>GTN'CL
M_7> 'YZ@0R[DYI"WOL+V5]XB4ABW<VU<F-M?*>7CA9Q<$WH#2IF.PN[Z%'KK
MMPF(.M^N\W4%<H]N+XO]?U>Y0LG9+".48^R=*T ,/S"/JCET"!/OFG.0UW9)
MA]6T12W<1^32-!]]]8H,LX3^L4/_=TT:D$HEO&O<;MSC#N<N>[RSK:C-H:6Q
M_%_95]M)!\U;IEXXIE<P;<,;CW[YR3L].?SWH^GSY\\/=O:FNSLPO^<[N[LO
M=I^\V/YC,<5?GOW[T8>//WWD=]XN%Z_/\_7G-P;M%#B/<^#(^N!_/[" PVJY
MV^:!]>D=?OQY> )GZ!U^//FT[7M/GNU[I\'7+ 4C?>J]S:HD.@]R,.KUA[[W
M:>#M'NSL']PZPZY/]B?&FQ"!@9TE;]P*^-G>TZTG^WM;3Y_N[[M-@.]\=5@.
MZIR&=S+\]>AT^,X;_F=X^/GLZ%>P.X:_#D\&QX=#[].'P?%:*.;UVS==N BO
M'[]=-9WOH3S49[,!>FY1>+N;MZZ=V>N&M1Z#UH3K?0F+_:RDRO?^S][.[LI'
M\/SO9.%Y/,?XXF]9#C;0AVPL^&^P?._[KO[I&A=*WHT.VN[W-L@6X8 7;(E5
MV_'VC4K9P*;>0:B0]TN!HT-7[U(\C.5%%"$X&CK3@8H.LWP!7#=PLSZMHC]?
M-06WL%=!5%@I(S 7L2.MF9CX&1=VL&<%XQ3G<8@P6QOZQS"P\\.+649YY6F_
MI^+?=>0>F5( ^P.<.(DEPM-PP]SN85GS"3-2Y'D"]M9>#G2^0<DZ>C?P,VL[
MMKW/G)=!3M8+&,I%+X:-TH3 D;DQ(X:2IXHK4*NB[6D+,]&*C-8J^@F$!F8$
MMIEE$LO,\9 LE':XAP+43I>%O,\8$(2WJ=0XE0B*,^GW:GCI=W58LP 7*9AG
MZ-V@N8VS.5;/VAS66?]GG0N"?W,=.3L:Z9<V]M6842><+!H379APL2YYQN&%
M_\-9+NC%/+.>5YX7<^R8L%A,N.)'H2FNZ"?'L[[M?7V[5/A:JL[>HL:EZ_[B
M;AL"=&27)G?NNF(B 5=\M.ZG'JGC,!2Z7^6<GXY..1T'3;")@X"\M_,J*>-%
M$J-'C=Y&=V:$;!1CT*,D+F91/=OS94-[NTNK_L7>+5KU;890AY%_L*ML?/V-
M,CYYI8]LE[#EV5W][[_)8+?A"'C>X@=0<SS^^-O)X-.U7><U]\CV#CY9\Y"$
M<;%(@N5+O"[1%N*SU"9UF<<=E4#X5')WWHG MSBF4OWM\$!M@7*CFI&'^D;
MO8!+!A_LU8E=;<SE:Z89#W2RPNNW)P9 #O_X17,5GOEEL[['Z^+N(7^Q-2F4
MR[_6LBSD0OR+I-PU%E7WU+[]B3QT_W[TC_$XBB:31W?@L+PN>Y*/T.5'NX3.
MR#+Z6L+$0NPAL:4^O);BT\*!3-;.I4Z?XRS=.CPZ5(X>=0[?QKV8;5^!%ML?
M5.1%&3*/WNSN\0\YU?*;WK.>B1\_'OQ L_W^V^R=?/Q-L8S.15C/U%\TC\,P
MB=I>=/F/ZHM[WK6XZ[W?5H >6$TKJP$N<J_8Q]Y3[X?C''O;.S_0;'>??],.
MUZ-ZMYEU8=+^?4XL[/)RM)"Q3PZ.(3="9+Q^25S$#EE+:H6H0*&L9&KMM<).
M-EX-IWYG;V.\>;>.D?=76O:W*0J\126:$C-.%^+MZO<&JG$D]?)072-#*T]^
M=Z^EB**-PY"#Q&PY):%?]U2_>7GITFIY2<LTJU1$0:Z8431%/W%[>S""SS*)
MW=PD\,H;,*JXHH&A^V#0J#1>'AZKUOVM<RBF7Z+<19YA0Z5 '$\/W?Z^O=L?
ME5A.J",7-;&"8TFK.7:<RJC2@9/$XT)](^VAY?3E/G _CQJM4<H;=6:T7'T<
MB@A5[=XLP&2P>4"N>/VEZ@IV)1KI]RPB,0$34!4R^K1E&=P;N;$8\9G6UH&)
M_WQ5K>9;6TQXSEWRKS!VL_<S5]%0[0,J7 I $R]OF%6C\J7; '81+!%(A HP
M+IG/K;*7INL7* @C4O8*+;:A - :ZZ== ^9SZ33@SF]A14^H)L)<1756>=72
M6+8%$ .K@J8PWDS825%AA504<OC&^@&6F09V?TNK>-7=9NVKQ]Q^57)@2A-J
M<W!_;85O"MUJCOH,N[6A+MX1IU_.@3UY$Z":W,K!W/:&7P-DL_IU;7!.9A<8
MD09/29$]B3V$8Y2RC=NBH'X/%^'$R52&S4!ZE$1NW"MP(E_U1L&WK8=0@BMS
MEDF<ZNK,KB:V=?T)C);=C3#<A-M,I7)V_ _1*4M)8=:E8'FT2& 30]5JD&]0
MN=3"4X597LH<L!P?Q$I,Q7YA-38G'MFA(96F+*GXY=+W_LA&"HN3RIYJ4)RF
M0H#HB8 U%7!N;7#-NG@T-:%DR=5$*5 ;1F\3K'&V^C+%J::X[@GKFM@-,R&L
M7JP0UI!3B>" ,&2E($6I_@:>LJOE-GU5G2,PP+Q/-901%A>Y=&83K /9W! =
MZ)4"&N.;*5/S[5W5.]KOU;?T%1/)'1!NE9?4KW)TC1"CUXPPYNV=6!0!<W]T
MTZF21 \C@#/<O5>O4"H[L? - CY?' .#S\%,D>1$ O;O)@0F ;I"-$&& K1P
M*5]*@2\1CDW)IZ=3QJ[RPX*:#W IFOXE[AS_NM^[Y/?8#2')BBJ/U(]AF0B_
M'J.7(Z9VC20K.9)MI ^S;$YGF*B.I'*&)3=)5>':UEAO+8;[G8/#7#GG1(>M
M&D!&16@G"2H_:J.)2TA"UTJ 0 ILIG<B8\$L/XFNA1D,291.&:.M]2'@Q@OL
MPHHZ#6QNVFV09.-QE6,E=Z':+Q<K>BG??KSZX/G]B%<_V[MJO'KW65LD]R%B
MNZ:([8U"9!_H6O%+L@G_UUPN_KL6*GL(A-W#0%C[[:A?_Y;(R]U67/P YW;S
MJ,+5SL*-%MRABWI%WAIW?C0ZHX)SLA/_5JB<02V#TC&E]K9WGN@:?1Y.ZP)A
M%A4"(HQ(;ZASA!4;P&ALJIQ1I=ML8_E81@8PE@;B,.:A=E0!"TS 7:V>@R A
M6I8<6&,"-(Z0B(U9Z XDEL_,I"S:/4%%Q2+SA6I.I*@R<SRV%KQ\L]N)KIQM
M=%T1N\C: *HY)3P27!>ZZ<0G4C.7#&)H*'6T;5O](?X2X8JNML_.G@1Y!%:S
MWA)W/U8>1M<IM&/0V>^4 OC:NW GRBW4W$DF(YQ(&J*7T=XX^!AU=% >DPBW
MFH"7X X%N08-IH1GH]2[*-7VQ1(@OKJYEA39J@LD_M5%'IW'646(_9P\'G2V
MPZP[?NS;U9U1;SQHVNI&MT7!I,1N*X1"NNY;M_L]48*]UXNKEI=Y#97/4J?O
MK)AESY.9/\0DOD6JK*[W'P,KX( :%?O7KKX-="28VPE</+'2ZUZ'?N_*+?BT
MJ8Q^*R[KT-TX5.XX.HNBD"F:6^ @1DL1)3ID,9YES#>,VU6 P$OV'],2&5A?
M%EISK-AM!)$=%PP6I] R+01>R[AWV >&=E=NTHK%HTL6UHO[+[!4U'V=YA3G
M@F"(SFUEDM?:3H*(6'"[ <F?8R1AR^>AGLKCJ&0H1.,#J96O ($ EXS9:\U@
M:P1V=QXE\!;MMY]4V!^(8"2P2UDG7;GGIT[.K%K5W!#E"70)OR6-IAE,OE0>
M4BXH:+BI+=>5HJ!")*'KJR4]1O#'U)A .3%'AD" *'\XB@_=4/8.0!1^5Z"#
MA-7IKY(_&W:+*-K@%+NE 1/1=$P,A^NJ:K>81/+J4A+3=BJ,QA04 3D)NEX&
MEBG> *=KH<4?"@^GK!K.G&=)E2*=U:-'M!+Z_:JVG4Z,J./:" Y68(I+:B"V
M2EO!P>*TTJ1>#\/K]ACLGQ+W5$D8VJ012._K*[E6:[-DQYC3$>\;1FGU!.N5
M$+(9-R)1W(%?7>?W+?4M%XA99]^Z$391D2O*KTSE$FFM5M]**^YEW4430VCR
M0+Z5#%DW;@YT_8W!)4UU%PJ\P76;YOGVSC/W1%K%8&FW:F.T-B.-8$RG_E"U
M<@-FFN(-2I1227!+%#!1'-W^G;SZ$@53 ]JX#M[6G?'=Q7.0'EUCV*O1BFJV
M%LWYM?Z,6J$?P?DS0"(!,)(&6?#D)QSV6#7_19475<"T[IS$B[U]+6DP[IGE
MN)<?@A$0+:,I-GD;-50(V\*MUA#"N%<8*RU4V>^MT%^NQXIXVZ51Q#B*0E9$
M&).U5*CD;G,_>W6$!*D  .F+VEAV#R.8A5FZK[BKTS=PA?6//9*L@?G(!6J[
M%A+F>#GFAH ]!3:4>!K,RV\_R'9T#/KUV?'P]-3[#0O_/[[W'45E1IW3I-M8
M[?A!5.$517 TT$X,.EHF8#J!CN.'[,%0-V0$6L[%-ARL05RBCVQ\I=J[:FUZ
M1\L:H.3_>3<X&_[?%8V>;S^$P0;*/8AA'%P6PG#\>0H&Z,F5 Q__:AU@_X:_
M-Q.X<S0@4VOSY-&;__-I<')V='@$?Y]YQX-?AO_W)M[/QO NOD:7\]F:M#7G
MGX='/_U\!CMXX.Z@];E=-O1]G[EC4"+R^+S\ME*K]2,\:2YR4]IY\W;Y%]F$
MNZ4?#&[\13;N)M2#$#%_D6VX6_JYP9[=^-#.T&?_<&H_V*G]A3A./0S[ \8Q
MGCS$,6YD%C;=-T>.$^M:D%N$!N1XH8."HPR.)^R*ONBK!$J,;^DJGB_QH7P/
MSU<WYLOSORR0Z]ZS&YI^!R]N.,#>_3 =[Q$+OX$0O%N1/8")Y6FTY)G]A?35
M;UO __VK"."G#P+X^R*>6BB^ T%=70EU>EO(J\/_#'[Y]&%XZGU\[PW_Y_/1
MV>_>K\/3,Q!&WM$QL,/CX^'AV=%'\BO_[/W/9QCA_>_X[1J@63$!>7CRR]'Q
M@&8$\QM<(2/UX[&3D3H\.?KX[K+9[S[_3CBG=,Q4!>?MJE-^Z>*PXJJ.?AG2
MC-Y>CB^\]79P.GRGEG-R^OF4CV9P? R'HPX/1UL5A3_H6)^3F[KSKVLN>%!-
MJZ*4*OT=W]O;V7OB/?$/=G9PHMXT#U2:59"F6**I*OW^ZQ^[^\"@=Q\_\39V
M_3U^OMC4WU-!!C6+DB=;WO34[_=:/MYG:/[F%P<KHC&WLSW_7:61.^768HX[
M/S950F\W=U3]0<=Y!)]1G%P=QGT@JZ=Z-J*O<W&V!2Y@R.AE$RNAO8 !$S8H
M3]#\EHO\[\.*]^T5%Q'F<'0MUZRSP%XC8.3H;IJT:C"_&J2XK^_@CBD4YS!=
MOU>OIS=0#>[%VI6S8;1B+$AN6\=&H&=8KW#?5+. D]C=>0R/X6*=(]&30(#;
M C[?N7='== &=F$?D/JX<POW#4H U5934+2.=(%DWX8\@&]K8342WL])W\)X
MJT5/&(2E/52HPFJ&#W@6WT?X[]G"WP(E_S["O]\[!+7L?4/XWZ5P:Y7]>_[3
MINR_=)5[6RCJU2HW=%')IC=.XLE$$2Z!;".SL A9P!T"1#3 O+16!O0@]W\,
MN7^<N9!'H^4JN57CCO=BAUNF"\QU;Z\N8CU%XRZ%J]ZU( WW]A[#,TH:FGOE
M2L.]=L7E@7W?D'T_Z6;?8%"^_WCR"[50.?UY<#+T/A\?G7F#WP8G[]@R:^?-
MZU92E&%6PL!1Z7W2/-JE0%#T&D1\8*!V;!0=E4O[A"VUC2<'3-.;]E.Z+3GU
M=?_O*A%7X:Y,"NY#R_L>./8#QUXKQW[:X-B*NN6^-.&DT +"C6@A9^3G3Q_#
M"(J?X^TCHZJ&4M;OP4VB*L>V"Z? R5K>@*=0W/FU.9K@2@I/)AT4")04Y6/I
M*MY@-:VKPDXB8<3P'S@(T4;+$CGM]L7.OQBWZ\X7BW4*M%HZ.!*W?'HP*V:M
M&[)@TD8W3=\)JOR$B7L;UKHW^SWW ::02Y7E#4$C@]NRJ51F-AZC/ZL@09U@
M]V!'0 ]PNG>]3Z>LL, D>+LVU*D[L'&JW$I68K8RC#',.Z*,96/W8DL6+(G0
M!F^;(+IT[YXXAL:UKO *QK3W]'9\W]*,YZ5V7M]ET\&W.M45C$WJ);>>65RA
M@YWV[/_]U-YF"L+UNEP^W=_=W=_=NP==+A_:2-Z?-I)OO[V3Y+?%-&TTE*??
M(I<758ZER*9.]YHMW%!SF0/S%R3$.$4H-ZPK(ZNEA%=2"0O\EQ.4I-O;9^GV
M]EDWO^OWXH(K3&>BLC6:M =2BD@E:]1G3%7<PMN_1$M3*E=P<:0I<"QYBJH
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M=82LR6\'SE/M@O)H4?%GV,B)?K7Y:OU7;\5&!>2A.N<.-=G$%X<3ZW<@AZ*
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M<7??&(^$DR5,@%C1HA0O'R+UZ/ODH%:()R2/K%)9120ZYE7;JV8<CZF :-#
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M;OKF:)05KTY Q6!,6@5"8M-,57BGE)DJZ[\FCGRK[D5^KVP%27$3HA6MF[?
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ME4'T&--28YQ)RH91J!6>KI8'KEF JT-9O@[D08WM,M"9))*_U.V+:.O=.VH
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M!E[NI#G2=,2792YHOX>53927W):!S_BP^G)CSGP:D7. JN<Y(^P']H =/'C
M;N?VXHV$O^0_?+9PH7?5!]+4@O\:"&"S]SZ2JM"AE=<8I]0>VVGQ?'AT*)!Y
MMG;!; "3C%QI=3'#9A=MZHBP;@NHUHS<!KRP($/6*O.E7,1X/J)F8&YVM*<[
M;VS8:KS%EY_L>+787)R"ICGF8-FF1_T[K(@H=CJN02<8W'2#JP WFN:C&A6K
M&N--1ZNOYZ93R"J*ODAVIKC157"F 2>N'.=NM_#&F(4J5$* 4%1?W$@2C_Y*
M6T^^-\LND,'XT@&>+#'9W[FQ@K2X5$T9U'[8":9X;+!P\WYY.;-UU9V@$^2I
M#:#!'L!: #6.@]6-@#].@LO2"6X;_^#H/QINX$ZA  \_#(Y^.863.SK^G\]'
M)T?#4]\;?/HT''PXO61"MZY+O+! [6R8=N0U;U4B.]+!48H9AG%D-SMS8?TM
M"1^KA[FAMS'ZE?'N?-W2>EZHI^XM0RV#T^0EPU$EYK4@$.A @)U(6,/FZ8@4
M2FS:#GC5L^>X?'F=X=@7-@Y52CT1)]XAYGW($1TY:>^-4V*$P52:DK5WG6K9
M5SH#W*")U"')^%0I:^VYKLY*J?5R8.P)_0,GS,W9"><QK-7\CEU0S1P@_E8K
MDL[I:%^I% TJ Y)HJ2C1==]5VR;EB1S_UZD]+&<*!9Z!J;*\)NL)*8HI'((T
M1B6Y,(P1)]/'RFXPD]"Q3 5'>;RP5>M:JW/5"M2XV%I.)XVBD(T_0F-33O)(
MTI5X@Y7=C<(!AFA@@)C^(70<U&P7K+]H#8$(PEBOG;\Z=4Y,;BF;%Z6E(\NG
M9=<DK[FPR9-]&1QO%+@.!"5Q$F1,V3'+1^U @&7XIBP:\X4Z[Q/FYU0+ELJ>
MY3%S9C_AH"!5Z(J!;DU3KGIS#O7?677]?D=FG1D#M[G?&[5D#NH+K"I>:@X#
M6!WU:+66($Z$NS>;B8#,$MWER:T;6;E\6&_H'C+[.REHJ+;>\FL2:)NX5<BU
M!KS%\M:T(N,0IR/)9GE>0WAYH0ZSD^.Y++25IZ.Z:8[,[EJI_<-,G[6!L*6'
MT]F3V2:+"*E[U =/CY:,=685'' ;H"A('#;7+F3KW$4?1LA8HVN7K@IMXD3Z
M)5$HP3NA:1LEB%T2!-5!C)G_UGJQR2MPJU@W:3B0NG,K3*?.$Z]=0TCC&^1D
M^)--OUUPHRN.8%N;Y:.;+<=#%@_I4XS#FCO+52*Y4\\2 CMH9[;VPE8MA>BK
MW^L"4$)67V,]"ALE4[#L[NYB'@%A-%8I)CL9Y6)!5A9JFZKG-LE+[A+6O0-P
MV.T[HW326N+)-57.?N]:.N</Z5)Z]N!2^I[,RJ5'FQH-X5@ ;@BIB47@ID=/
M:2N@F+]'N>3H5!)X4P,C*NT:W9[UH)!B?UBCCYK+.8FBA/,=]77KA(I#=J44
M*7<4JG! SF1+7)JE;UU>':ZU%.36%[4AQ2VP\V%.W3]PX>.:-\UA,,P&UFNK
M/]46WUC"5:DCD3KVF)@HY28+>+-%.NA((]H13K[7Y.06CJQ##RH;[]K*L;>!
M@HEP>,81I>_:1VS/8+.IW%KD?FV%UK/U60K?E36]1JM+2HN]%(%\;V<+9JK"
M]TK177424VF#/E^4;=-NT0H;JK>&=VUYAS00+FPIS[NAR\Y;-,<N'X!M=655
MF<!M]AT[6R$@K["T+1^!I8F.:V:RQ9QXYK)VQ:8Z5./V73"19AY%HVDX9F/K
MR1.%6H@KJHK'B=;B96SHT%Y-A19])TL=]K%&G5;A6IQHF-%/2O\N5G(0Y-(Z
M=&BAE&KUO> D?VHQ9N5=Z>P^A@:F;'??I%2LX,9 5WE.O6?11>APXAJ68:RV
M%Q]6^"]4 55<2>H8!9Q#(C!78 ]%N_RQO3*Q[A>K)0:/%3E=5\N:HTPG"%^D
MRC^_;KFBJN&'7V<!J!#"JD^0B+7+]SB3CG$.WVA):$3X-M VIK,2VW5QF#C+
MJ[D=M\>!2(T/=/_$PO+K&@CI50RKS:PT!&D;E,O&Y=WU3;\/C7I.?LUX):!K
M7=MI,6T:C):^MAF"A??(=&HC\AK>9:6+H_"V6)2^BF+-B]@!DW!C;"UJ0G5?
M9C-;+9@6GT+'W@IEMYGLJ#W5M_B)% :&G=ML&4VKO)JS0.^O-0W9:O6GV63;
M<=%6-H>L>W/MK%C54KVG]*1W<;' 1+63J,@2@IIZY7W0N>HD&;D(>J"CR.O$
MJX"E_,3H377$.IWN"6=;W_5G0)SLW&&+0]$^AV87E!I;QUBSXKBJ%8U@*9/Z
MUC8$EVM)]Q>G#*T89PN&H#"%478&C,Y'PZPAC*E2GQAY1WOIUB;;7)QS9-_H
M5D9D-J4PG A^1>R2&+&OG*J!89(&KV7,GCJG8RWS5K/HX'(V+?$[!0>%BFZI
M4EKU6SN";\+:%3?"+#/*KJ)REPD1LPN?+^F)-*ZOJC9XBC5U"1V) 1J+F!;,
M!3]T(B/X7WA/Z#-6NB- U!"J;E/@=3%HHP+J\4K0_=NN88>KPE$Y)Z8J#D0R
MK]S,NP;Y8,#I.O3CYMI9VK5&LN+$+<;G4;?&EQ?['HD(E=H-7^L.M58B=)!C
MCJ:A.7U?-2MP\P8<7U8;6_ -MI#,R()%(ZI*L,-(629"I_DH5O#U6-944?\9
M@9V)LZI(.J.[K+RJUAIS$)QCE#C6@*IQ::S*NF$#W 8XV([]1_7#/7_PP]T,
M/BN>4XMJ8'2*"K-<H=UQ4:#;C 99I'G2 +&5%YD] MD*_),HK U!C\_B7 5B
M+&*U.TO+-0#"'Z935 ]MS%8,F4H!=;\G"J[;;,FY V,PUE]XG[=/MP^WL<+@
MX-DK_M_+/2*[6[L'OG*(X 3^J,(IYX(*.BFB)DH0S&C;]EZ('4&GK@J^EP0F
M16B4R'/^J( )A;' B>&V$%XQ":*6_>GW/H$2C E@4]@6NSK;W5-\NZK4UCTL
MB&O2I,-@#@1/Y@<ZKQAL*8*]S^;Q6*K2I<0@0XA5?GP=*"IC2P(=I7]0(XMS
M2LZ.H\E52O>LL$-[*KP3=3^/LX2H*#!-T?%Q2LPEE65@>FK7L0@U1#6U(@<*
MGJ/E28B)VJU+F4,YQ6DHZ6\6Y'.)HJ'+:)YAHJ0ZGCGEE"B8XQ#L'M+D'$#$
M9A8C4UQ<)JJ86.^:*0KZLXJYX27AN4Q(RHA[0,E6>A+]JFP^.[##!)*'Q(/C
M+!W(=Z;#1N]CNXBO)=O!S/RKE$;*99&\?>5RC=..,H*8,_14H;*<,Y]@88[0
M:YZ@+JYRWM3O.25"C.U* 3G*2>&TR[QD1^,?TE_%5[!%"'B2Y>(1T@JA;V=>
MZH;O5YCG#QPO>_$@I[]O&B8V0OW/ST=OC\Z\@4<9UM_8>^KF\_AI>$RMF4^&
M'X:#TZ$W^.ED./P%=O)&\[IYIHP8];J"9Z!T?VR<"-]SI:'^5#5+C O..F88
M%E4;C7Z8):SA,RY:9-$-_\,[\_F-M\$S&1)>.#!H*74$GL%?_ XLIONS36_#
M[IWK.\USE;O?K#U0"X=UZ#?B5-1H9 ^\U?"!F):?+[;Q"576R*U$$%8A#F,2
MH(%JT.";EA74'2R,I'^%+1LTR#(WLJ2255TK%F P3O(?^&-)HU6%H/CP-*+F
M6@)O@9](<0%&4V.PGAEV'<1)'F&W%WIF'LU'_ ]JX).K)'O9 ^UM!PDWS8-Y
M0>!9AC_/]23C7&8@"< %3 ]&N^XQX'+U48CLM@X"):CS$P>A/])8S+JD%#-$
M!4ZJ]C(0HD O#*GO]E E9^1$1$W#Z[EG9R_=*7QF6L?:91%98-4 6<!8H^&T
M[]!Z28D](-69!BVI)RXP9K]GGC[5P[.[SIR0^XUN.@W#7T0)M6\3=7,>8X%"
M[9WV8?CV[/##XLJ(L,^_A\FWNZWJ[8#J='&CR;9^NP9?[.ZVRML_(DN$FPFI
M!G]*K>431@I'8C9!$KN;"^NUFB@:9^^>HX\C\;5&?NH5BPPA^/H]BYU(^Q;M
M+RE45PWI?>+;?1Z<R$=A,4/A<+H)#%+@:%EOUH.,D<Y#F5Z8["Q]?5#+.6<?
MEZKDLZL!G7HEI<_B$U93&MB1*)GX@A"B6+ TW>GWR%J(52P4E&H0G\4L7LC<
M+94ZSET^W<&F#7NV>+*UM=E%2M^J=UDL6C%5WW!EO)&3&-MZ![F:I1($JA92
M3T^U;#N/K#.PCZ#?$ZG[^@AU&+D((1L3'"5\_?C(M)=GA#QI@TH;2%4=QM-(
MQAX#)8UU[3A"I57<)IQ+J+ S &7 5RG]4\+'2R!H.MU9$&+MZ@6A__B>!'>Y
MK< T0"0-3] _K72H^N0E!UNG\5*N,/$<J8&MB0<+0J4-6LA>M3AT<;XTU99I
MYG&A MVJ=,Y4:RWQFJW"-!&JM;!9:)%!:?W*U\::/@PN:UB#9P)9D4H!<:YP
MXU T!4D]$":W\&YJ$M";2"DB1K(/Y4[!H&6<\Z$=<<_@4]6V!'U<_=X9VOO8
M&U>7"\?G<<)UU04^@Y_OOCB0= _E,2X\;/R'@;M 9R+HAU_LR,/ <]YAA\38
MP(FF5GVV-?PS_L7PSRK  F6>'7WTGO:1#NZ7"#%7$^]#A$NF)]QXP.Z+YR8>
M '\\Q]'%B<<+?;K'W(QZ<\_)8V "7^(;SUNZSY)OGG$,\6'I 4F=K*BDVH8[
MM*@U=%>/ ]BX7+68GG9PV*/]7 '9(''(?&#9KYI/.1O7\OTO(&40XN@W8(#]
M7OLS^)T";:)E'HIZBN%71+ITGL;H8"W@> %< C9YE*#;$*5O&0EG,W#K[V-"
MBY1=T?#KP$CP[23"@&LAG\3 9<)QB%=R9IX<&6S4E-DCIYUT,'+=&86:4UJ'
M^DJ!,UEQ1*=+)+%BZA/)<)DN2<#*9O&((_?=AZU]<[890X,XD&H8+!008PU0
MMTT*2Y 4F>8.K6Q;<P@3\S3]O>%R7^19.L425ZT#8-KB)(CS_[^];^UMX]JR
M_"Y _Z&0QAU(0-G7DA])[-L&9(F)U:U(AB0GG1G,AQ)9E"JF6+Q5I&SV8/[[
MG/T\^YPZ14F18[9[W&CD6A)9==YG/]9>B^B2Z&QT]GQQ+3I8&@B;+2Z<T<]:
M%[EH!F+<"@FX1AP.'<8T!9*4YF.=]L\0F4:1-!0/+[(F1#'I8[&\SUEO\ZMS
MTDIE5EY12Y.LH9:4?:UQL+U'.]\"80]+6/%Z%&*ZD6)DJLED02K@-V1 ,T:R
M9!C8#<>D9;?1U\D[TVW)7(>-]XL2U@^?ZT 4"P DX9F#94Q4<[Q+W/9@)YZY
M$PM02)=G5V@LHM_!%@&KE&NH'8$@G ,H;HIJ(F%S.$XJVGXU1_&7MUQ$_CU2
M2.ES!R"XY+PH-'*)HRV_/2\&A%^2*I+T&#?671!0J<+SX!R+3TC\[3-(.5\W
MM?V5.@:L@SLNB<I,TQ:<H\!1*=U4-)25DGQ<RV,M2FPRSJ.ZE(5 $ZY &SK/
M83!'-7X"3')B#"5=N?(34'\RE@L3#]Z49H0#OT78A:LQF_@0+$0W%9-!:-1)
M\@?,'XS>E.QVXNYBB$\=QV[B4_/+!V-V'N]Z?:&.I*4,L\U91($DY][G=IB)
MS5QYO60,P**C.[26*E;<?<^>[&Q]V$:".TSES8PT8HNWE5PH"&)Z!'F4IHR5
M72EZAA-QXW8MP!N) 6L;937'WEU"DY[HGX*9"%$@OZ,+1$UDWWEB/E>W90JP
M1.:!UAY,RAOD$'$]:B.RL7## O@1DI'D^>N:& Q.]HF>B%-@<@D#QP@@7RYC
M5 FGI^&+KY2& SOC981I?L(&0$9RSIDL,@QH.P*R!9<XGI,^_$'A+6>XW'8P
M26MR8A\IC0'D&HZ-H,#&.A:^E$V>IQ8ZYH'CA0XL$#?FT EP2MPM?^"'$"0I
M-72_7+D0(\]1<]G.OH=!AFMA. $&O269OX1 X/QQ(U;G!5(DWZ 4FCS:6*I<
M^*"D@?@'@A(X2[0@AJOH]EI,C;EG[YB5<_=9PIJ[-JRY+SG[8ZK,.5N4ZPEL
M[FI@$^\"HA;UX\GGH2J2JK^4RTYW4WW95'!*#,,(4. \$,B3*@8(;PF@N-@%
MVMP@'T@SUM%V1=I2Q(U,=.MR:-0HX/'(<LV3V["Y'$X<[,H#>KN #!KJHXC$
MA-^3)]K@[O,*2[ DCA8$OGHB7NQY<-?&D6FTN8'P41T:[>9%/5HF1D)Z'XO,
M$G?LG,K(N 6]9T"*[T@V;-6F1M*<&J1Z$&TOQ0SXVI+)LGNM:(R;:Y"QODE'
M!K<EWF 6<T165>_K_TM?09F_@8"G]2^]@FX1]78/OH)?@Q=;"5P+WQ3UQ=LW
M#,4:(X+$E^/8=!9-*L;YQ"T8<)($]5ZN23SU3UV0]SK.CKE[W72FQ%!:.BT(
MM8P\Q0#;909NAE55K(K"!Y3L51^2D:U&"#_4PI43B;0_YK2I;YW4 X@BSX6X
M\=_ "QPR643/>&9^. 53-;V$->G#BMR0PRD>"ZX]C#/@,#A2J]4"1QY.ZA9A
M\UHEQG&T@/JZ$VDSVC'A*-FXUV-[ATQ++B@AV0/A:@BRIT;5X%H44XG?#*=*
M,-+:9CG\!4%HM;N)-2E\K%QK[.V,RE5/7T.L?E<=F3,Z,7"M!I>7%W2@ ].=
M6D-6!])# 4)LUR@2ZA;*@M(?F/WQR1]&_.?^FJA-Y@ZJ/3BJW;7L?'@Q +)]
MO1&OW6\1KX=%O +S8E?,"[HQT7*W%-DL?B(2[K-BB4$CO* KB00A<,'"0"SQ
M8_BZCE$1"C1E$W<^8L9=7T4[P^V$B9NDD;N220"7J36%+9.(;A?-M,LJP@)\
MH:1@%&PK "[!\-!(M!GA-FZ'3N5\ZL;9.7V:8-JTW)F ^8%-"'SK=-MKVFA1
ML:LD=C'- Y-9RB792;1:>P # "+8(O89U-ERO1$5IB.( 2K9,1M1"M:7O;Y.
MSU!VP(!^@6H=1>]"R76,<97PYK&$.)UQA>A>6"1L3]GH#G^*W4Y3UV8ZIS([
MDR5Q;0%)AP1G20[LR_OPN^K#^^W"%G<QNJF'G!T"X3/FE:NF.F8B=028 >*$
M#JU<*?2ID#\">>V!=R/AQ$5FJ?>%!.!L.:'OXO$H807:\Q.N))I@626SI&G5
M-IJM@>$6[7'=FVC#9<);O21#SBUXV'U+TWFT<<#+(ST96>ZAT1_V4SBV>Q)S
MWM9C ^NOMV:?VI#!K?'NXWKZ""IYT3:4@#> *8XJ5J&C$(-?9M[7BT\ 6( F
M5Q;3AR.#"+\ITR.]S_5UYR"]E'9QB38RA130S)2L(6 2W9KAR<P)A +)0ZXN
MT\0=^"-HQZ-(Z!A3@O""*")$1 "=Y@1@"+=GEWI<,;:!:RM&*Y<#^P0U9*))
M5['QV G\R\5$/$O_?!@*,,+Q0_@RO"0X8\+C2(1QT M@28=07MS" N\7_&"K
M0C2<<RDV-V#,[I@@,3GDNEG:*J([?5URYN:[Q%/RYXSG>^V.9V% ;3HF[9U"
M]!9U39ME#W'#8@@)$'<>798,T=*]@/%,W0"4D7:MR3%:M)BB &_N:>:D:((O
M2_H\T_MQB(F^)%7^Q,UP[=RI8M[6Y8T7OD/Q6>;)[IK<&-6_P;\S<S^&8S$7
M/:]SK(VB*E!TXK6>)Z.QR^G78URI&+@:.?^-\68 2Z!3F?FY<T(2E$WI_2DJ
MI5D]J9\E2OH\!'^&XD?$C$R6$P_K>J*FSX.HJ;+A^;JMR-\D1J@+$(;FVU02
MMC-GX3TR,>F&ZY'@;O+E-A)G)S<MP/RGB+1^#W$-JX-+N7F/!<)1&*[B4GY
M93#>#D_OJN$KTZ IPP^-L^&B=<-="K1T&&[1-;C7S]6]CNY G2-OET.+ 9B?
MOM*@&@Z-&T7$3.H627D =$H98YPJ,ML-KX*![IHT\G9LUZ<LYP"V2$$_];XC
MU:WN$4(?N'VQK5YK'0:>:*G98Q:'%]/KB4Q-)Y\*?VPP[&OB0=ZG>^-3I:':
MMA<C%>EUN4Q1X$S"M8IU$M0BG8B+R;ABX3<94X7(<XA4HVK>B[O3IF7ZA&BE
M5?@6F;CT--WW3=GG<*I3V/.[^]"9<:%17O!6'UJ4O.!:(_F)* ;HP?1+ =-W
MV<A2NZ"C<_K@ 8Y%V3P%+T:%]8YDQNZO,@CV]%L0[&%!,,92Q47.&BU1A+W*
M%,/QA<HO+&Z:"*7@Z<-ZK-,XDA3F)+Z <?;"&F>_N$8ZM[Z8EO5B354Y+]0,
M^\?AZY_1/X?SXL@-#8S;K^44TNJ'KSN%:F)]8<S!F#UDSX/'Q490->_2.;B-
MK@8-N\086@C)3R@Y0VA>/=B<]_NQ+"9S/*PLNMG7-:BZ =E@T_&D&DK"&)#
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M(4RZU*-B*2+DY?2F:NKI>F!\?O2*%JBXE5!=,<"+*8BI\R!M;M""A6IXH1B
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M*.<T H.:+3_\=Q "%N9=@L@6LV+X6=1;[C_B533B8,#!H!XA(\D^,9*$X7/
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M4;J;<PD@&8S$NO&8?<4ON".?WW%'OF/Z&QDHU_[!?,CEZ..^<(+G#8@B16$
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M!IL;-<TN@8/\(2!+$")?SU<^JR%J76'!R'3L;A[V[D5C5^E/X,W3 K)FG.0
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MJF'CS OPX/=Q!0$3B7R!E\Y85YKI.8)6*%E+D#B&ZA*&B%$EUXP_[HY7J!5
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M4+^0TZGV(R,[X M]C;&NCB 4(&@B=+,TS==.9JH-N(A:</(NL2:VH?:[D")
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M2P$"% ,4    " !904M9Z[E0MSX#  !-"P  $0              @ $
M8V]H<BTR,#(T,3 Q,"YX<V102P$"% ,4    " !904M9CV&@&5L&  "_0P
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M+FAT;5!+ 0(4 Q0    ( %E!2UD3Y?EXP0\  ,4P   1              "
L :/B  !D.#@X-C R9&5X.3DQ+FAT;5!+!08     !@ & '\!  "3\@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>d888602d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cohr-20241010.xsd" xlink:type="simple"/>
    <context id="duration_2024-10-10_to_2024-10-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000820318</identifier>
        </entity>
        <period>
            <startDate>2024-10-10</startDate>
            <endDate>2024-10-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-402">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-10-10_to_2024-10-10"
      id="Hidden_dei_EntityCentralIndexKey">0000820318</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-413">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-414">2024-10-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-415">Coherent Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-416">PA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-417">001-39375</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-418">25-1214948</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-419">375 Saxonburg Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-420">Saxonburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-421">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-422">16056</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-423">(724)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-424">352-4455</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-425">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-426">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-427">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-428">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-429">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-430">COHR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-431">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-10-10_to_2024-10-10" id="ixv-432">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
